메뉴 건너뛰기




Volumn 104, Issue 1, 2014, Pages 1-52

Global guideline for type 2 diabetes

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD GLUCOSE MONITORING; BLOOD PRESSURE MONITORING; CARDIOVASCULAR RISK; COPING BEHAVIOR; DIABETES CONTROL; DIABETES EDUCATION; ELDERLY CARE; EYE EXAMINATION; FOOT CARE; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE ORGANIZATION; HEALTH CARE PLANNING; HEALTH PROGRAM; HOSPITAL PATIENT; HUMAN; KIDNEY INJURY; LIFESTYLE MODIFICATION; MEDICAL DECISION MAKING; NERVE INJURY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT CARE; PATIENT EDUCATION; PRACTICE GUIDELINE; PSYCHOLOGICAL WELL BEING; QUALITY OF LIFE; SCREENING TEST; SELF MONITORING; BLOOD; CARDIOVASCULAR DISEASES; DEVELOPED COUNTRY; DEVELOPING COUNTRY; DIABETES MELLITUS, TYPE 2; DISEASE MANAGEMENT; HEALTH; INTERNATIONAL COOPERATION; METABOLISM;

EID: 84898540957     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2012.10.001     Document Type: Article
Times cited : (406)

References (324)
  • 1
    • 84898543276 scopus 로고    scopus 로고
    • World Health Organization. Screening for type 2 diabetes. Report of a World Health Organization and International Diabetes Federation meeting. WHO/NMH/MNC/03.1 Geneva: WHO Department of Noncommunicable Disease Management
    • World Health Organization. Screening for type 2 diabetes. Report of a World Health Organization and International Diabetes Federation meeting. WHO/NMH/MNC/03.1 Geneva: WHO Department of Noncommunicable Disease Management; 2003. http://www.who.int.
    • (2003)
  • 2
    • 0042825242 scopus 로고    scopus 로고
    • Microvascular complications at time of diagnosis of type 2 diabetes are similar among diabetic patients detected by targeted screening and patients newly diagnosed in general practice: the Hoorn screening study
    • Spijkerman AMW, Dekker JM, Nijpels G, et al. Microvascular complications at time of diagnosis of type 2 diabetes are similar among diabetic patients detected by targeted screening and patients newly diagnosed in general practice: the Hoorn screening study. Diabetes Care 2003; 26: 2604-2608.
    • (2003) Diabetes Care , vol.26 , pp. 2604-2608
    • Spijkerman, A.M.W.1    Dekker, J.M.2    Nijpels, G.3
  • 3
    • 7244240929 scopus 로고    scopus 로고
    • Prevalence of macrovascular disease amongst type 2 diabetic patients detected by targeted screening and patients newly diagnosed in general practice: the Hoorn Screening Study
    • Spijkerman AMW, Henry RMA, Dekker JM, et al. Prevalence of macrovascular disease amongst type 2 diabetic patients detected by targeted screening and patients newly diagnosed in general practice: the Hoorn Screening Study. J Intern Med 2004; 256: 429-436.
    • (2004) J Intern Med , vol.256 , pp. 429-436
    • Spijkerman, A.M.W.1    Henry, R.M.A.2    Dekker, J.M.3
  • 4
    • 11944263528 scopus 로고
    • Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis
    • Harris MI, Klein R, Welborn TA, et al. Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis. Diabetes Care 1992; 15: 815-819.
    • (1992) Diabetes Care , vol.15 , pp. 815-819
    • Harris, M.I.1    Klein, R.2    Welborn, T.A.3
  • 5
    • 82955247909 scopus 로고    scopus 로고
    • IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030
    • Whiting DR, Guariguata L, Weil C, et al. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 2011; 94: 311-321
    • (2011) Diabetes Res Clin Pract , vol.94 , pp. 311-321
    • Whiting, D.R.1    Guariguata, L.2    Weil, C.3
  • 6
    • 0033808127 scopus 로고    scopus 로고
    • The ADDITION study: proposed trial of the cost-effectiveness of an intensive multifactorial intervention on morbidity and mortality among people with type 2 diabetes detected by screening
    • Lauritzen T, Griffin S, Borch-Johnsen K, et al. The ADDITION study: proposed trial of the cost-effectiveness of an intensive multifactorial intervention on morbidity and mortality among people with type 2 diabetes detected by screening. Int J Obes Relat Metab Disord 2000; 24: S6-S11.
    • (2000) Int J Obes Relat Metab Disord , vol.24
    • Lauritzen, T.1    Griffin, S.2    Borch-Johnsen, K.3
  • 7
    • 0037270905 scopus 로고    scopus 로고
    • Glucose screening and the risk of complications in type 2 diabetes mellitus
    • Schellhase KG, Koepsell TD, Weiss NS, et al. Glucose screening and the risk of complications in type 2 diabetes mellitus. J Clin Epidemiol 2003; 56: 75-80.
    • (2003) J Clin Epidemiol , vol.56 , pp. 75-80
    • Schellhase, K.G.1    Koepsell, T.D.2    Weiss, N.S.3
  • 8
    • 0030007192 scopus 로고    scopus 로고
    • Bewirkte das flächendeckende glukosurie-screening der 60er und 70er jahre im Osten Deutschlands tatsächlich den erhofften Prognosevorteil für die frühzeitig entdeckten Diabetiker?
    • Schneider H, Ehrlich M, Lischinski M, et al. Bewirkte das flächendeckende glukosurie-screening der 60er und 70er jahre im Osten Deutschlands tatsächlich den erhofften Prognosevorteil für die frühzeitig entdeckten Diabetiker? Diabetes Stoffwech 1996; 5: 33-38.
    • (1996) Diabetes Stoffwech , vol.5 , pp. 33-38
    • Schneider, H.1    Ehrlich, M.2    Lischinski, M.3
  • 9
    • 0036674992 scopus 로고    scopus 로고
    • Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcome? UKPDS 61.
    • Colagiuri S, Cull CA, Holman RA. Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? UKPDS 61. Diabetes Care 2002; 25: 1410-1417.
    • (2002) Diabetes Care , vol.25 , pp. 1410-1417
    • Colagiuri, S.1    Cull, C.A.2    Holman, R.A.3
  • 10
    • 83755173339 scopus 로고    scopus 로고
    • Risk models and scores for type 2 diabetes: systematic review
    • Noble D, Mathur R, Dent T, et al. Risk models and scores for type 2 diabetes: systematic review. BMJ 2011; 343: 7163.
    • (2011) BMJ , vol.343 , pp. 7163
    • Noble, D.1    Mathur, R.2    Dent, T.3
  • 11
    • 0042743790 scopus 로고    scopus 로고
    • The diabetes risk score: a practical tool to predict type 2 diabetes risk
    • Lindstrom J, Tuomilehto J. The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care 2003; 26: 725-731.
    • (2003) Diabetes Care , vol.26 , pp. 725-731
    • Lindstrom, J.1    Tuomilehto, J.2
  • 13
    • 84898543221 scopus 로고    scopus 로고
    • World Health Organization. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia. Geneva: World Health Organization
    • World Health Organization. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia. Geneva: World Health Organization; 2006. http://www.who.int.
    • (2006)
  • 14
    • 80052695368 scopus 로고    scopus 로고
    • Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus
    • Report of a World Health Organization Consultation
    • Report of a World Health Organization Consultation. Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus. Diabetes Res Clin Pract 2011; 93: 299-309.
    • (2011) Diabetes Res Clin Pract , vol.93 , pp. 299-309
  • 15
    • 65749098338 scopus 로고    scopus 로고
    • Canadian Diabetes Association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada
    • Canadian Diabetes Association Clinical Practice Guidelines Expert Committee.
    • Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes 2008; 32: S95-S98. http:// www.diabetes.ca.
    • (2008) Can J Diabetes , vol.32
  • 16
    • 84898543674 scopus 로고    scopus 로고
    • National Collaborating Centre for Women's and Children's Health and the National Collaborating Centre for Chronic Conditions. Diagnosis and management of type 1 diabetes in children young people and adults. London: National Institute for Clinical Excellence
    • National Collaborating Centre for Women's and Children's Health and the National Collaborating Centre for Chronic Conditions. Diagnosis and management of type 1 diabetes in children young people and adults. London: National Institute for Clinical Excellence; 2004. http://www.nice.org.uk/ CG015NICEguideline.
    • (2004)
  • 17
    • 33746433601 scopus 로고    scopus 로고
    • Effects of quality improvement strategies for type 2 diabetes on glycaemic control
    • Shojania KG, Ranji SR, McDonald KM, et al. Effects of quality improvement strategies for type 2 diabetes on glycaemic control. JAMA 2006; 296: 427-440.
    • (2006) JAMA , vol.296 , pp. 427-440
    • Shojania, K.G.1    Ranji, S.R.2    McDonald, K.M.3
  • 18
    • 0035487864 scopus 로고    scopus 로고
    • Interventions to improve the management of diabetes in primary care, outpatient, and community settings: a systematic review
    • Renders CM, Valk GD, Griffin SJ, et al. Interventions to improve the management of diabetes in primary care, outpatient, and community settings: a systematic review. Diabetes Care 2001; 24: 821-833.
    • (2001) Diabetes Care , vol.24 , pp. 821-833
    • Renders, C.M.1    Valk, G.D.2    Griffin, S.J.3
  • 19
    • 84921431000 scopus 로고    scopus 로고
    • Diabetes care: the effectiveness of systems for routine surveillance for people with diabetes
    • Griffin S, Kinmonth AL. Diabetes care: the effectiveness of systems for routine surveillance for people with diabetes. Cochrane DB Syst Rev 2000; 2: CD000541.
    • (2000) Cochrane DB Syst Rev , vol.2
    • Griffin, S.1    Kinmonth, A.L.2
  • 20
    • 0041667823 scopus 로고    scopus 로고
    • Diabetes and telemedicine. Is the technology sound, effective, cost-effective and practical?
    • Klonoff DC. Diabetes and telemedicine. Is the technology sound, effective, cost-effective and practical? Diabetes Care 2003; 26: 1626-1628.
    • (2003) Diabetes Care , vol.26 , pp. 1626-1628
    • Klonoff, D.C.1
  • 21
    • 33947370435 scopus 로고    scopus 로고
    • Home telemonitoring of patients with diabetes: a systematic assessment of observed effects
    • Janna M, Pare G. Home telemonitoring of patients with diabetes: a systematic assessment of observed effects. J Eval Clin Pract 2006; 13: 242-253.
    • (2006) J Eval Clin Pract , vol.13 , pp. 242-253
    • Janna, M.1    Pare, G.2
  • 22
    • 36148937517 scopus 로고    scopus 로고
    • The effectiveness of nurse and pharmacist directed care in diabetes disease management: a narrative review
    • Davidson MB. The effectiveness of nurse and pharmacist directed care in diabetes disease management: a narrative review. Curr Diab Rev 2007; 3: 280-287.
    • (2007) Curr Diab Rev , vol.3 , pp. 280-287
    • Davidson, M.B.1
  • 23
    • 84898544269 scopus 로고    scopus 로고
    • Department of Health. National service framework for diabetes: delivery strategy. London: Department of Health
    • Department of Health. National service framework for diabetes: delivery strategy. London: Department of Health; 2002. http://www.doh.gov.uk/nsf/diabetes/research.
    • (2002)
  • 24
    • 34250832776 scopus 로고    scopus 로고
    • How effective are expert patient (lay led) education programmes for chronic disease
    • Griffiths C, Foster G, Ramsay J, et al. How effective are expert patient (lay led) education programmes for chronic disease. BMJ 2007; 334: 1254-1256.
    • (2007) BMJ , vol.334 , pp. 1254-1256
    • Griffi, C.1    Foster, G.2    Ramsay, J.3
  • 25
    • 33646006732 scopus 로고    scopus 로고
    • Effectiveness of community health workers in the care of persons with diabetes
    • Norris SL, Chowdhury FM, Van Let K, et al. Effectiveness of community health workers in the care of persons with diabetes. Diab Med 2006; 23: 544-556.
    • (2006) Diab Med , vol.23 , pp. 544-556
    • Norris, S.L.1    Chowdhury, F.M.2    Van Let, K.3
  • 26
    • 34447319145 scopus 로고    scopus 로고
    • Quality of primary care in England with the introduction of pay for performance
    • Campbell S, Reeves D, Kontopantelis E, et al. Quality of primary care in England with the introduction of pay for performance. N Eng J Med 2007; 357: 181-190.
    • (2007) N Eng J Med , vol.357 , pp. 181-190
    • Campbell, S.1    Reeves, D.2    Kontopantelis, E.3
  • 27
    • 36549074067 scopus 로고    scopus 로고
    • Quality of diabetes care in the UK: comparison of published quality of care reports with results from the quality and outcomes framework for diabetes
    • Khunti K, Gadsby R, Millett C, et al. Quality of diabetes care in the UK: comparison of published quality of care reports with results from the quality and outcomes framework for diabetes. Diab Med 2007; 24: 1436-1441.
    • (2007) Diab Med , vol.24 , pp. 1436-1441
    • Khunti, K.1    Gadsby, R.2    Millett, C.3
  • 28
    • 77956705089 scopus 로고    scopus 로고
    • Has pay for performance improved the management of diabetes in the United Kingdom?
    • Alshamsan R, Millett C, Majeed A. Has pay for performance improved the management of diabetes in the United Kingdom? Prim Care Diabetes 2010; 4: 73-78.
    • (2010) Prim Care Diabetes , vol.4 , pp. 73-78
    • Alshamsan, R.1    Millett, C.2    Majeed, A.3
  • 29
    • 0035091345 scopus 로고    scopus 로고
    • Effectiveness of selfmanagement training in type 2 diabetes. A systematic review of randomized controlled trials
    • Norris SL, Engelgau MM, Narayan KMV. Effectiveness of selfmanagement training in type 2 diabetes. A systematic review of randomized controlled trials. Diabetes Care 2001; 24: 561-587.
    • (2001) Diabetes Care , vol.24 , pp. 561-587
    • Norris, S.L.1    Engelgau, M.M.2    Narayan, K.M.V.3
  • 30
    • 77952926335 scopus 로고    scopus 로고
    • National evidenced based guideline for patient education in type 2 diabetes
    • Canberra: Diabetes Australia and the NHMRC
    • Colagiuri R, Girgis S, Eigenmann C, et al. National evidenced based guideline for patient education in type 2 diabetes. Canberra: Diabetes Australia and the NHMRC; 2009.
    • (2009)
    • Colagiuri, R.1    Girgis, S.2    Eigenmann, C.3
  • 31
    • 1542267436 scopus 로고    scopus 로고
    • Diabetes self-management education core outcome measures
    • Mulcahy K, Maryniuk M, Peeples M, et al. Diabetes self-management education core outcome measures. Diabetes Educator 2003; 29: 768-803.
    • (2003) Diabetes Educator , vol.29 , pp. 768-803
    • Mulcahy, K.1    Maryniuk, M.2    Peeples, M.3
  • 32
    • 0036823501 scopus 로고    scopus 로고
    • Self-management approaches for people with chronic conditions: a review
    • Barlow JH, Wright C, Sheasby J, et al. Self-management approaches for people with chronic conditions: a review. Patient Educ Couns 2002; 48: 177-187.
    • (2002) Patient Educ Couns , vol.48 , pp. 177-187
    • Barlow, J.H.1    Wright, C.2    Sheasby, J.3
  • 33
    • 34249910310 scopus 로고    scopus 로고
    • National standards for diabetes self-management education
    • Funnell, M, Brown T, Childs B, et al. National standards for diabetes self-management education. Diabetes Care 2007; 30: 1630-1637.
    • (2007) Diabetes Care , vol.30 , pp. 1630-1637
    • Funnell, M.1    Brown, T.2    Childs, B.3
  • 34
    • 36749048769 scopus 로고    scopus 로고
    • From DSME to DSMS: developing empowerment based diabetes self-management support
    • Funnell M, Tang TS, Anderson RM. From DSME to DSMS: developing empowerment based diabetes self-management support. Diabetes Spectrum 2007; 20: 221-216.
    • (2007) Diabetes Spectrum , vol.20 , pp. 216-221
    • Funnell, M.1    Tang, T.S.2    Anderson, R.M.3
  • 35
    • 1542267436 scopus 로고    scopus 로고
    • Diabetes self-management education core outcome measures
    • Mulcahy K, Maryniuk M, Peeples M, et al. Diabetes self-management education core outcome measures. Diabetes Educator 2003; 29: 768-803.
    • (2003) Diabetes Educator , vol.29 , pp. 768-803
    • Mulcahy, K.1    Maryniuk, M.2    Peeples, M.3
  • 36
    • 0027092849 scopus 로고
    • Meta-analysis of diabetes patient education research: variations in intervention effects across studies
    • Brown SA. Meta-analysis of diabetes patient education research: variations in intervention effects across studies. Res Nurs Health 1992; 15: 409-419.
    • (1992) Res Nurs Health , vol.15 , pp. 409-419
    • Brown, S.A.1
  • 37
    • 0026726192 scopus 로고
    • Evaluating diabetes education. Are we measuring the most important outcomes?
    • Glasgow RE, Osteen VL. Evaluating diabetes education. Are we measuring the most important outcomes? Diabetes Care 1992; 15: 1423-1432.
    • (1992) Diabetes Care , vol.15 , pp. 1423-1432
    • Glasgow, R.E.1    Osteen, V.L.2
  • 38
    • 0032605188 scopus 로고    scopus 로고
    • Evidence suggesting that a chronic disease self management program can improve health status while reducing hospitalization
    • Lorig KR, Sobel DS, Stewart AL, et al. Evidence suggesting that a chronic disease self management program can improve health status while reducing hospitalization. Med Care 1999; 37: 5-14.
    • (1999) Med Care , vol.37 , pp. 5-14
    • Lorig, K.R.1    Sobel, D.S.2    Stewart, A.L.3
  • 39
    • 70249142112 scopus 로고    scopus 로고
    • Individual patient education for people with type 2 diabetes mellitus
    • Duke SAS, Colagiuri S, Colagiuri R. Individual patient education for people with type 2 diabetes mellitus. Cochrane DB Syst Rev 2009; 1: CD005268.
    • (2009) Cochrane DB Syst Rev , vol.1
    • Duke, S.A.S.1    Colagiuri, S.2    Colagiuri, R.3
  • 40
    • 0011816661 scopus 로고    scopus 로고
    • Improving chronic illness care: translating evidence into action
    • Wagner EH, Austin BT, Davis C, et al. Improving chronic illness care: translating evidence into action. Health Aff 2001; 20: 64-78.
    • (2001) Health Aff , vol.20 , pp. 64-78
    • Wagner, E.H.1    Austin, B.T.2    Davis, C.3
  • 41
    • 0036633075 scopus 로고    scopus 로고
    • Self-management education for adults with type 2 diabetes
    • Norris SL, Lau J, Smith SJ, et al. Self-management education for adults with type 2 diabetes. Diabetes Care 2002; 25: 1159-1171.
    • (2002) Diabetes Care , vol.25 , pp. 1159-1171
    • Norris, S.L.1    Lau, J.2    Smith, S.J.3
  • 42
    • 0037145818 scopus 로고    scopus 로고
    • Patient selfmanagement of chronic disease in primary care
    • Bodenheimer TS, Lorig K, Holman H, et al. Patient selfmanagement of chronic disease in primary care. JAMA 2002; 288: 2469-2475.
    • (2002) JAMA , vol.288 , pp. 2469-2475
    • Bodenheimer, T.S.1    Lorig, K.2    Holman, H.3
  • 43
    • 84898539878 scopus 로고    scopus 로고
    • National Institute for Clinical Excellence. Technology Appraisal 60. Guidance on the use of patient-education models for diabetes. London: National Institute for Clinical Excellence
    • National Institute for Clinical Excellence. Technology Appraisal 60. Guidance on the use of patient-education models for diabetes. London: National Institute for Clinical Excellence; 2003. http://www.nice.org.uk.
    • (2003)
  • 44
    • 84898542415 scopus 로고    scopus 로고
    • Education and home glucose monitoring. In: Gerstein HC, Haynes RB (eds). Evidence based diabetes care. Hamilton, Ontario: BC Decker
    • Piette JD, Glasgow RE. Education and home glucose monitoring. In: Gerstein HC, Haynes RB (eds). Evidence based diabetes care. Hamilton, Ontario: BC Decker; 2001: 207-2051.
    • (2001) , pp. 2007-2051
    • Piette, J.D.1    Glasgow, R.E.2
  • 45
    • 0038826343 scopus 로고    scopus 로고
    • Meta-analysis of randomized educational and behavioral interventions in type 2 diabetes
    • Gary TL, Genkinger JM, Gualler E, et al. Meta-analysis of randomized educational and behavioral interventions in type 2 diabetes. Diabetes Educator 2003; 29: 488-501.
    • (2003) Diabetes Educator , vol.29 , pp. 488-501
    • Gary, T.L.1    Genkinger, J.M.2    Gualler, E.3
  • 46
    • 3843138376 scopus 로고    scopus 로고
    • Self-management education programs in chronic disease. A systematic review and methodological critique of the literature.
    • Warsi A, Wang PS, LaValley MP, et al. Self-management education programs in chronic disease. A systematic review and methodological critique of the literature. Arch Intern Med 2004; 164: 1641-1649.
    • (2004) Arch Intern Med , vol.164 , pp. 1641-1649
    • Warsi, A.1    Wang, P.S.2    LaValley, M.P.3
  • 47
    • 24144496118 scopus 로고    scopus 로고
    • Ecological approaches to self-management: the case of diabetes
    • Fisher EB, Brownson CA, O'Toole ML, et al. Ecological approaches to self-management: the case of diabetes. Am J Public Health 2005; 95: 1523-1535.
    • (2005) Am J Public Health , vol.95 , pp. 1523-1535
    • Fisher, E.B.1    Brownson, C.A.2    O'Toole, M.L.3
  • 48
    • 33645329591 scopus 로고    scopus 로고
    • Deploying the chronic care model to implement and sustain diabetes selfmanagement training programs
    • Siminerio L, Piatt G, Emerson S, et al. Deploying the chronic care model to implement and sustain diabetes selfmanagement training programs. Diabetes Educator 2006; 32: 1-8.
    • (2006) Diabetes Educator , vol.32 , pp. 1-8
    • Siminerio, L.1    Piatt, G.2    Emerson, S.3
  • 49
    • 63849142649 scopus 로고    scopus 로고
    • Access to diabetes selfmanagement education: results of national surveys of patients, educators and physicians
    • Peyrot M, Rubin R, Funnell M, et al. Access to diabetes selfmanagement education: results of national surveys of patients, educators and physicians. Diabetes Educator 2009; 35: 246-263.
    • (2009) Diabetes Educator , vol.35 , pp. 246-263
    • Peyrot, M.1    Rubin, R.2    Funnell, M.3
  • 50
    • 54249136276 scopus 로고    scopus 로고
    • Diabetes education, Integrating theory, cultural considerations, and individually tailored content.
    • Osborn CY, Fisher JD. Diabetes education. Integrating theory, cultural considerations, and individually tailored content. Clin Diab 2008; 26: 148-150.
    • (2008) Clin Diab , vol.26 , pp. 148-150
    • Osborn, C.Y.1    Fisher, J.D.2
  • 51
    • 50649096340 scopus 로고    scopus 로고
    • Educator talk and patient change: some insights from the DESMOND (Diabetes Education and Self Management for Ongoing and Newly Diagnosed) randomized controlled trial
    • The DESMOND Collaborative.
    • Skinner TS, Carey ME, Cradock S, et al, the DESMOND Collaborative. Educator talk and patient change: some insights from the DESMOND (Diabetes Education and Self Management for Ongoing and Newly Diagnosed) randomized controlled trial. Diab Med 2008; 25: 1117-1120.
    • (2008) Diab Med , vol.25 , pp. 1117-1120
    • Skinner, T.S.1    Carey, M.E.2    Cradock, S.3
  • 52
    • 55949100422 scopus 로고    scopus 로고
    • Analysis of the 2004-2007 literature on therapeutic patient education in diabetes: results and trends
    • Albano MG, Crozet C, d'Ivernois JF. Analysis of the 2004-2007 literature on therapeutic patient education in diabetes: results and trends. Acta Diabetol 2008; 45: 211-219.
    • (2008) Acta Diabetol , vol.45 , pp. 211-219
    • Albano, M.G.1    Crozet, C.2    d'Ivernois, J.F.3
  • 53
    • 84898542144 scopus 로고    scopus 로고
    • Building peer support programs to manage chronic disease: seven models for success. Oakland, CA: California Health Care Foundation
    • Heisler M. Building peer support programs to manage chronic disease: seven models for success. Oakland, CA: California Health Care Foundation; 2006.
    • (2006)
    • Heisler, M.1
  • 54
    • 18944373829 scopus 로고    scopus 로고
    • Lay health workers in primary and community health care for maternal and child health and the management of infectious diseases
    • Lewin S, Dick J, Pond P, et al. Lay health workers in primary and community health care for maternal and child health and the management of infectious diseases. Cochrane DB Syst Rev 2005; 17: CD004015.
    • (2005) Cochrane DB Syst Rev , vol.17
    • Lewin, S.1    Dick, J.2    Pond, P.3
  • 55
    • 84861121520 scopus 로고    scopus 로고
    • Diabetes buddies: peer support through a mobile phone buddy system
    • Rotheram-Borus MJ, Tomlinson M, Gwegwe M, et al. Diabetes buddies: peer support through a mobile phone buddy system. Diabetes Educator 2012; 38: 357-365.
    • (2012) Diabetes Educator , vol.38 , pp. 357-365
    • Rotheram-Borus, M.J.1    Tomlinson, M.2    Gwegwe, M.3
  • 56
    • 0037464786 scopus 로고    scopus 로고
    • Identifying depression in primary care: a comparison of different methods in a prospective cohort study
    • Henkel V, Mergl R, Kohnen R, et al. Identifying depression in primary care: a comparison of different methods in a prospective cohort study. BMJ 2003; 326: 200-201. http://www. who-5.org.
    • (2003) BMJ , vol.326 , pp. 200-201
    • Henkel, V.1    Mergl, R.2    Kohnen, R.3
  • 57
    • 0027569430 scopus 로고
    • The MOS 36-item shortform health survey (SF-36): II, Psychometric and clinical tests of validity in measuring physical and mental health constructs.
    • McHorney CA, Ware JE Jr, Raczek AE. The MOS 36-item shortform health survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993; 31: 247-263. http://www.SF-36.org.
    • (1993) Med Care , vol.31 , pp. 247-263
    • McHorney, C.A.1    Ware Jr., J.E.2    Raczek, A.E.3
  • 58
    • 0029031359 scopus 로고
    • Assessment of diabetes-related distress
    • Polonsky WH, Anderson BJ, Lohrer PA, et al. Assessment of diabetes-related distress. Diabetes Care 1995; 18: 754-760. http://www.proqolid.org.
    • (1995) Diabetes Care , vol.18 , pp. 754-760
    • Polonsky, W.H.1    Anderson, B.J.2    Lohrer, P.A.3
  • 59
    • 84965520932 scopus 로고
    • The CES-D scale: a self-report depression scale for research in the general population
    • Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977; 3: 385-401.
    • (1977) Appl Psychol Meas , vol.3 , pp. 385-401
    • Radloff, L.S.1
  • 60
    • 0035374580 scopus 로고    scopus 로고
    • The prevalence of comorbid depression in adults with diabetes, A metaanalysis.
    • Anderson RJ, Freedland KE, Clouse RE, et al. The prevalence of comorbid depression in adults with diabetes. A metaanalysis. Diabetes Care 2001; 24: 1069-1078.
    • (2001) Diabetes Care , vol.24 , pp. 1069-1078
    • Anderson, R.J.1    Freedland, K.E.2    Clouse, R.E.3
  • 61
    • 0034917842 scopus 로고    scopus 로고
    • Association of depression and diabetes complications: a meta-analysis
    • de Groot M, Anderson R, Freedland KE, et al. Association of depression and diabetes complications: a meta-analysis. Psychosom Med 2001; 63: 619-630.
    • (2001) Psychosom Med , vol.63 , pp. 619-630
    • de Groot, M.1    Anderson, R.2    Freedland, K.E.3
  • 62
    • 4444253630 scopus 로고    scopus 로고
    • Relationship of depression and diabetes self-care, medication adherence, and preventive care
    • Lin EH, Katon W, Von Korff M, et al. Relationship of depression and diabetes self-care, medication adherence, and preventive care. Diabetes Care 2004; 27: 2154-2160.
    • (2004) Diabetes Care , vol.27 , pp. 2154-2160
    • Lin, E.H.1    Katon, W.2    Von Korff, M.3
  • 63
    • 0036511428 scopus 로고    scopus 로고
    • Comorbid depression is associated with increased health care use and expenditures in individuals with diabetes
    • Egede LE, Zheng P, Simpson K. Comorbid depression is associated with increased health care use and expenditures in individuals with diabetes. Diabetes Care 2002; 25: 464-470.
    • (2002) Diabetes Care , vol.25 , pp. 464-470
    • Egede, L.E.1    Zheng, P.2    Simpson, K.3
  • 64
    • 33845999622 scopus 로고    scopus 로고
    • Cost-effectiveness of systematic depression treatment among people with diabetes mellitus
    • Simon GE, Katon WS, Lin EH, et al. Cost-effectiveness of systematic depression treatment among people with diabetes mellitus. Arch Gen Psychiatry 2007; 64: 65-72.
    • (2007) Arch Gen Psychiatry , vol.64 , pp. 65-72
    • Simon, G.E.1    Katon, W.S.2    Lin, E.H.3
  • 65
    • 65749098338 scopus 로고    scopus 로고
    • Canadian Diabetes Association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada
    • Canadian Diabetes Association Clinical Practice Guidelines Expert Committee.
    • Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes 2008; 32: S95-S98. http://www.diabetes.ca.
    • (2008) Can J Diabetes , vol.32
  • 66
    • 84898539305 scopus 로고    scopus 로고
    • Scottish Intercollegiate Guidelines Network. SIGN 116. Management of diabetes: a national clinical guideline
    • Scottish Intercollegiate Guidelines Network. SIGN 116. Management of diabetes: a national clinical guideline, 2010. http://www.sign.ac.uk/pdf/sign116.pdf.
    • (2010)
  • 67
    • 84898540939 scopus 로고    scopus 로고
    • The National Collaborating Centre for Chronic Conditions. Type 1 diabetes in adults. National clinical guideline for diagnosis and management in primary and secondary care
    • The National Collaborating Centre for Chronic Conditions. Type 1 diabetes in adults. National clinical guideline for diagnosis and management in primary and secondary care. http://www.rcplondon.ac.uk/pubs/books/DIA/index.asp.
  • 68
    • 84898540573 scopus 로고    scopus 로고
    • National evidenced based guideline for patient education in type 2 diabetes. Canberra: Diabetes Australia and the NHMRC
    • Colagiuri R, Girgis S, Eigenmann C, et al. National evidenced based guideline for patient education in type 2 diabetes. Canberra: Diabetes Australia and the NHMRC; 2009.
    • (2009)
    • Colagiuri, R.1    Girgis, S.2    Eigenmann, C.3
  • 69
    • 84855185039 scopus 로고    scopus 로고
    • Standards of medical care in diabetes
    • American Diabetes Association.
    • American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 2012; 35: S11-S63.
    • (2012) Diabetes Care , vol.35
  • 70
    • 33244458334 scopus 로고    scopus 로고
    • Psychosocial factors and diabetes mellitus: evidence-based treatment guidelines
    • Petrak F, Herpertz S, Albus C, et al. Psychosocial factors and diabetes mellitus: evidence-based treatment guidelines. Curr Diabetes Rev 2005; 1: 255-270. http://www.diabetespsychologie. de/en/guidelines.htm.
    • (2005) Curr Diabetes Rev , vol.1 , pp. 255-270
    • Petrak, F.1    Herpertz, S.2    Albus, C.3
  • 71
    • 58249107150 scopus 로고    scopus 로고
    • Prevalence and correlates of depression among U. adults with diabetes. The behavioral risk factor surveillance system 2006.
    • Li C, Ford ES, Zhao G, et al. Prevalence and correlates of depression among U.S. adults with diabetes. The behavioral risk factor surveillance system 2006. Diab Res Clin Pract 2009; 83: 268-279.
    • (2009) Diab Res Clin Pract , vol.83 , pp. 268-279
    • Li, C.1    Ford, E.S.2    Zhao, G.3
  • 72
    • 77954620551 scopus 로고    scopus 로고
    • Effect of interventions for major depressive disorder and significant depressive symptoms in patients with diabetes mellitus: a systematic review and meta-analysis
    • van der Feltz-Cornelis CM, Nuyen J, Stoop C, et al. Effect of interventions for major depressive disorder and significant depressive symptoms in patients with diabetes mellitus: a systematic review and meta-analysis. Gen Hosp Psychiatry 2010; 32: 380-395.
    • (2010) Gen Hosp Psychiatry , vol.32 , pp. 380-395
    • van der Feltz-Cornelis, C.M.1    Nuyen, J.2    Stoop, C.3
  • 73
    • 79951692037 scopus 로고    scopus 로고
    • Web-based depression treatment for type 1 and type 2 diabetic patients: a randomized, controlled trial
    • van Bastelaar KM, Pouwer F, Cuijpers P, et al. Web-based depression treatment for type 1 and type 2 diabetic patients: a randomized, controlled trial. Diabetes Care 2011; 34: 320-325.
    • (2011) Diabetes Care , vol.34 , pp. 320-325
    • van Bastelaar, K.M.1    Pouwer, F.2    Cuijpers, P.3
  • 74
    • 0032532409 scopus 로고    scopus 로고
    • Cognitive behavior therapy for depression in type 2 diabetes mellitus: a randomized controlled trial
    • Lustman PJ, Griffith LS, Freedland KE, et al. Cognitive behavior therapy for depression in type 2 diabetes mellitus: a randomized controlled trial. Arch Intern Med 1998; 129: 613-621.
    • (1998) Arch Intern Med , vol.129 , pp. 613-621
    • Lustman, P.J.1    Griffith, L.S.2    Freedland, K.E.3
  • 75
    • 0036276473 scopus 로고    scopus 로고
    • Psychological counselling in problematic diabetes. Does it help?
    • Snoek FJ, Skinner TC. Psychological counselling in problematic diabetes. Does it help? Diabet Med 2004; 19: 265-273.
    • (2004) Diabet Med , vol.19 , pp. 265-273
    • Snoek, F.J.1    Skinner, T.C.2
  • 76
    • 2442553221 scopus 로고    scopus 로고
    • Systematic review and meta-analysis of randomised controlled trials of psychological interventions to improve glycaemic control in patients with type 2 diabetes
    • Ismail K, Winkley K, Rabe-Hesketh S. Systematic review and meta-analysis of randomised controlled trials of psychological interventions to improve glycaemic control in patients with type 2 diabetes. Lancet 2004; 363: 1589-1597.
    • (2004) Lancet , vol.363 , pp. 1589-1597
    • Ismail, K.1    Winkley, K.2    Rabe-Hesketh, S.3
  • 77
    • 79956130401 scopus 로고    scopus 로고
    • Monitoring of Individual Needs in Diabetes (MIND): baseline data from the crossnational Diabetes Attitudes, Wishes, and Needs (DAWN) MIND study
    • Snoek F, Kersch NY, Eldrup E, et al. Monitoring of Individual Needs in Diabetes (MIND): baseline data from the crossnational Diabetes Attitudes, Wishes, and Needs (DAWN) MIND study. Diabetes Care 2011; 34: 601-603.
    • (2011) Diabetes Care , vol.34 , pp. 601-603
    • Snoek, F.1    Kersch, N.Y.2    Eldrup, E.3
  • 78
    • 84872114340 scopus 로고    scopus 로고
    • Effectiveness of medical nutrition therapy in diabetes
    • In: Franz MJ, Evert AB (eds).2nd ed. Alexandria, VA: American Diabetes Association
    • Pastors JG, Franz MJ. Effectiveness of medical nutrition therapy in diabetes. In: Franz MJ, Evert AB (eds). American Diabetes Association guide to nutrition therapy for diabetes. 2nd ed. Alexandria, VA: American Diabetes Association; 2012: 1-18.
    • (2012) American Diabetes Association guide to nutrition therapy for diabetes , pp. 1-18
    • Pastors, J.G.1    Franz, M.J.2
  • 79
    • 84861789102 scopus 로고    scopus 로고
    • Changes in physical fitness predict improvements in modifiable cardiovascular risk factors independently of body weight loss in subjects with type 2 diabetes participating in the Italian Diabetes and Exercise Study (IDES)
    • the Italian Diabetes Exercise Study (IDES) Investigators.
    • Balducci S, Zanuso S, Cardell P, et al, the Italian Diabetes Exercise Study (IDES) Investigators. Changes in physical fitness predict improvements in modifiable cardiovascular risk factors independently of body weight loss in subjects with type 2 diabetes participating in the Italian Diabetes and Exercise Study (IDES). Diabetes Care 2012; 35: 1347-1354.
    • (2012) Diabetes Care , vol.35 , pp. 1347-1354
    • Balducci, S.1    Zanuso, S.2    Cardell, P.3
  • 80
    • 20044395091 scopus 로고    scopus 로고
    • The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance
    • the Diabetes Prevention Program Research Group.
    • Herman WH, Hoerger TJ, Brandles M, et al, the Diabetes Prevention Program Research Group. The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance. Ann Intern Med 2005; 142: 323-332.
    • (2005) Ann Intern Med , vol.142 , pp. 323-332
    • Herman, W.H.1    Hoerger, T.J.2    Brandles, M.3
  • 81
    • 15944424370 scopus 로고    scopus 로고
    • Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the Diabetes Prevention Program
    • The Diabetes Prevention Program Research Group.
    • The Diabetes Prevention Program Research Group. Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the Diabetes Prevention Program. Diabetes Care 2005; 28: 888-894.
    • (2005) Diabetes Care , vol.28 , pp. 888-894
  • 82
    • 65749098338 scopus 로고    scopus 로고
    • Canadian Diabetes Association 2008 Clinical practice guidelines for the prevention and management of diabetes in Canada
    • Canadian Diabetes Association Clinical Practice Guidelines Expert Committee.
    • Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2008 Clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes 2008; 32: S95-S98. http://www.diabetes.ca.
    • (2008) Can J Diabetes , vol.32
  • 83
    • 84898548775 scopus 로고    scopus 로고
    • The National Collaborating Centre for Chronic Conditions. Type 2 diabetes: the management of type 2 diabetes. NICE clinical guideline 87. London: Royal College of Physicians
    • The National Collaborating Centre for Chronic Conditions. Type 2 diabetes: the management of type 2 diabetes. NICE clinical guideline 87. London: Royal College of Physicians; 2009. http://www.nice.org.uk/nicemedia/pdf/ CG87NICEGuideline.pdf.
    • (2009)
  • 84
    • 84898545463 scopus 로고    scopus 로고
    • National evidence based guideline for blood glucose control in type 2 diabetes. Canberra: Diabetes Australia and the NHMRC
    • Colagiuri S, Dickinson S, Girgis S, et al. National evidence based guideline for blood glucose control in type 2 diabetes. Canberra: Diabetes Australia and the NHMRC; 2009. http:// www.nhmrc.gov.au/guidelines/publications/di19.
    • (2009)
    • Colagiuri, S.1    Dickinson, S.2    Girgis, S.3
  • 85
    • 84855185039 scopus 로고    scopus 로고
    • Standards of medical care in diabetes
    • American Diabetes Association.
    • American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 2012; 35: S11-S63.
    • (2012) Diabetes Care , vol.35
  • 86
    • 40349108600 scopus 로고    scopus 로고
    • Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association
    • [Erratum in Diabetes Care 2010; 33: 1911], American Diabetes Association.
    • American Diabetes Association. Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association. Diabetes Care 2008; 31: S61- S78. [Erratum in Diabetes Care 2010; 33: 1911].
    • (2008) Diabetes Care , vol.31
  • 87
    • 34249864128 scopus 로고    scopus 로고
    • Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes
    • The Look AHEAD Research Group.
    • The Look AHEAD Research Group. Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes. Diabetes care 2007; 30: 1374-1383.
    • (2007) Diabetes care , vol.30 , pp. 1374-1383
  • 88
    • 0025083284 scopus 로고
    • Response of fasting plasma glucose to diet therapy in newly presenting type II diabetic patients (UKPDS 7)
    • UK Prospective Diabetes Study Group.
    • UK Prospective Diabetes Study Group. Response of fasting plasma glucose to diet therapy in newly presenting type II diabetic patients (UKPDS 7). Metabolism 1990; 39: 905-912.
    • (1990) Metabolism , vol.39 , pp. 905-912
  • 89
    • 0032983666 scopus 로고    scopus 로고
    • Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49)
    • Turner RC, Cull CA, Frighi V, et al. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). JAMA 1999; 281: 2005-2012.
    • (1999) JAMA , vol.281 , pp. 2005-2012
    • Turner, R.C.1    Cull, C.A.2    Frighi, V.3
  • 90
    • 0038144478 scopus 로고    scopus 로고
    • Randomized controlled community-based nutrition and exercise intervention improves glycemia and cardiovascular risk factors in type 2 diabetic patients in rural Costa Rica
    • Goldhaber-Fiebert JD, Goldhaber-Fiebert SN, Tristan ML, et al. Randomized controlled community-based nutrition and exercise intervention improves glycemia and cardiovascular risk factors in type 2 diabetic patients in rural Costa Rica. Diabetes Care 2003; 26: 24-29.
    • (2003) Diabetes Care , vol.26 , pp. 24-29
    • Goldhaber-Fiebert, J.D.1    Goldhaber-Fiebert, S.N.2    Tristan, M.L.3
  • 91
    • 10744224637 scopus 로고    scopus 로고
    • A simple meal plan emphasizing healthy food choices is as effective as an exchange-based meal plan for urban African Americans with type 2 diabetes
    • Ziemer DC, Berkowitz KJ, Panayioto RM, et al. A simple meal plan emphasizing healthy food choices is as effective as an exchange-based meal plan for urban African Americans with type 2 diabetes. Diabetes Care 2003; 26: 1719-1724.
    • (2003) Diabetes Care , vol.26 , pp. 1719-1724
    • Ziemer, D.C.1    Berkowitz, K.J.2    Panayioto, R.M.3
  • 92
    • 9644276892 scopus 로고    scopus 로고
    • Outcomes monitoring of health, behavior, and quality of life after nutrition intervention in adults with type 2 diabetes
    • Lemon CC, Lacey K, Lohse B, et al. Outcomes monitoring of health, behavior, and quality of life after nutrition intervention in adults with type 2 diabetes. J Am Diet Assoc 2004; 104: 1805- 1815.
    • (2004) J Am Diet Assoc , vol.104
    • Lemon, C.C.1    Lacey, K.2    Lohse, B.3
  • 93
    • 0242332273 scopus 로고    scopus 로고
    • Integrating medical management with diabetes self-management training, A randomized control trial of the diabetes outpatient intensive treatment program.
    • Polonsky WH, Earles J, Smith S, et al. Integrating medical management with diabetes self-management training. A randomized control trial of the diabetes outpatient intensive treatment program. Diabetes Care 2003; 26: 3048-3053.
    • (2003) Diabetes Care , vol.26 , pp. 3048-3053
    • Polonsky, W.H.1    Earles, J.2    Smith, S.3
  • 94
    • 2342586741 scopus 로고    scopus 로고
    • Diabetes selfmanagement training program in a community clinic improves patient outcomes at modest cost
    • Banister NA, Jastrow ST, Hodges V, et al. Diabetes selfmanagement training program in a community clinic improves patient outcomes at modest cost. J Am Diet Assoc 2004; 104: 807-810.
    • (2004) J Am Diet Assoc , vol.104 , pp. 807-810
    • Banister, N.A.1    Jastrow, S.T.2    Hodges, V.3
  • 95
    • 79960268164 scopus 로고    scopus 로고
    • Diet or diet plus physical activity versus usual care in patients with newly diagnosed type 2 diabetes: the early ACTID randomized controlled trial
    • Andrews RC, Cooper AR, Montgomery AA, et al. Diet or diet plus physical activity versus usual care in patients with newly diagnosed type 2 diabetes: the early ACTID randomized controlled trial. Lancet 2011; 378: 129-139.
    • (2011) Lancet , vol.378 , pp. 129-139
    • Andrews, R.C.1    Cooper, A.R.2    Montgomery, A.A.3
  • 96
    • 77955105254 scopus 로고    scopus 로고
    • Nutritional intervention in patients with type 2 diabetes who are hyperglycaemic despite optimized drug treatment: Lifestyle Over and Above Drugs in Diabetes (LOADD) study: randomized controlled trial
    • Coppell KJ, Kataoka M, Williams SM, et al. Nutritional intervention in patients with type 2 diabetes who are hyperglycaemic despite optimized drug treatment: Lifestyle Over and Above Drugs in Diabetes (LOADD) study: randomized controlled trial. BMJ 2010; 341: c3337.
    • (2010) BMJ , vol.341
    • Coppell, K.J.1    Kataoka, M.2    Williams, S.M.3
  • 97
    • 84898547913 scopus 로고    scopus 로고
    • Academy of Nutrition and Dietetics. Disorders of lipid metabolism evidence-based nutrition practice guidelines, Accessed: 26 June 2012.
    • Academy of Nutrition and Dietetics. Disorders of lipid metabolism evidence-based nutrition practice guidelines, 2011. http://www.adaevidencelibrary.com/topic. cfm?cat=26519. Accessed: 26 June 2012.
    • (2011)
  • 98
    • 12344259499 scopus 로고    scopus 로고
    • World Health Organization- International Society of Hypertension (WHO/ISH) hypertension guidelines
    • Whitworth JA, Chalmers J. World Health Organization- International Society of Hypertension (WHO/ISH) hypertension guidelines. Clin Exp Hypertension 2004; 26: 747-752.
    • (2004) Clin Exp Hypertension , vol.26 , pp. 747-752
    • Whitworth, J.A.1    Chalmers, J.2
  • 99
    • 0035850403 scopus 로고    scopus 로고
    • Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus, A meta-analysis of controlled clinical trials.
    • Boulé NG, Haddad E, Kenny GP, et al. Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus. A meta-analysis of controlled clinical trials. JAMA 2001; 286: 1218-1227.
    • (2001) JAMA , vol.286 , pp. 1218-1227
    • Boulé, N.G.1    Haddad, E.2    Kenny, G.P.3
  • 100
    • 0034682052 scopus 로고    scopus 로고
    • Low cardiorespiratory fitness and physical activity as predictors of mortality in men with type 2 diabetes
    • Wei M, Gibbons LW, Kampert JB, et al. Low cardiorespiratory fitness and physical activity as predictors of mortality in men with type 2 diabetes. Ann Intern Med 2000; 132: 605-611.
    • (2000) Ann Intern Med , vol.132 , pp. 605-611
    • Wei, M.1    Gibbons, L.W.2    Kampert, J.B.3
  • 101
    • 79955549960 scopus 로고    scopus 로고
    • Physical activity advice only or structured exercise training and association with HbA1c levels in type 2 diabetes: a systematic review and meta-analysis
    • Umpierre D, Ribeiro PA, Kramer CK, et al. Physical activity advice only or structured exercise training and association with HbA1c levels in type 2 diabetes: a systematic review and meta-analysis. JAMA 2011; 305: 1790-1799.
    • (2011) JAMA , vol.305 , pp. 1790-1799
    • Umpierre, D.1    Ribeiro, P.A.2    Kramer, C.K.3
  • 103
    • 84898544359 scopus 로고    scopus 로고
    • International Diabetes Federation. Position statement: bariatric surgical and procedural interventions in the treatment of obese patients with type 2 diabetes. Brussels: International Diabetes Federation
    • International Diabetes Federation. Position statement: bariatric surgical and procedural interventions in the treatment of obese patients with type 2 diabetes. Brussels: International Diabetes Federation; 2011. http://www.idf.org/ webdata/docs/IDF-Position-Statement-Bariatric-Surgery.pdf.
    • (2011)
  • 104
    • 84855185039 scopus 로고    scopus 로고
    • Standards of medical care in diabetes
    • American Diabetes Association.
    • American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 2012; 35: S11-S63.
    • (2012) Diabetes Care , vol.35
  • 105
    • 65749098338 scopus 로고    scopus 로고
    • Canadian Diabetes Association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada
    • Canadian Diabetes Association Clinical Practice Guidelines Expert Committee.
    • Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes 2008; 32: S95-S98. http:// www.diabetes.ca.
    • (2008) Can J Diabetes , vol.32
  • 106
    • 84898542362 scopus 로고    scopus 로고
    • National evidence based guideline for blood glucose control in type 2 diabetes. Canberra: Diabetes Australia and the NHMRC
    • Colagiuri S, Dickinson S, Girgis S, et al. National evidence based guideline for blood glucose control in type 2 diabetes. Canberra: Diabetes Australia and the NHMRC; 2009. http:// www.nhmrc.gov.au/guidelines/publications/di19.
    • (2009)
    • Colagiuri, S.1    Dickinson, S.2    Girgis, S.3
  • 107
    • 84898538873 scopus 로고    scopus 로고
    • The National Collaborating Centre for Chronic Conditions. Type 2 diabetes: the management of type 2 diabetes. NICE clinical guideline 87. London: Royal College of Physicians
    • The National Collaborating Centre for Chronic Conditions. Type 2 diabetes: the management of type 2 diabetes. NICE clinical guideline 87. London: Royal College of Physicians; 2009. http://www.nice.org.uk/nicemedia/pdf/ CG87NICEGuideline.pdf.
    • (2009)
  • 108
    • 0034641568 scopus 로고    scopus 로고
    • Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study
    • Stratton IM, Adler AI, Neil HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000; 321: 405-412.
    • (2000) BMJ , vol.321 , pp. 405-412
    • Stratton, I.M.1    Adler, A.I.2    Neil, H.A.3
  • 109
    • 0032511583 scopus 로고    scopus 로고
    • Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
    • UK Prospective Diabetes Study Group.
    • UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-853.
    • (1998) Lancet , vol.352 , pp. 837-853
  • 110
    • 53749096863 scopus 로고    scopus 로고
    • 10-year follow-up of intensive glucose control in type 2 diabetes
    • Holman RR, Paul SK, Bethel MA, et al. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008; 359: 1577-1589.
    • (2008) N Engl J Med , vol.359 , pp. 1577-1589
    • Holman, R.R.1    Paul, S.K.2    Bethel, M.A.3
  • 111
    • 0029147687 scopus 로고
    • Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study
    • Ohkubo Y, Kishikawa H, Araki E, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 1995; 28: 103-117.
    • (1995) Diabetes Res Clin Pract , vol.28 , pp. 103-117
    • Ohkubo, Y.1    Kishikawa, H.2    Araki, E.3
  • 112
    • 45149131667 scopus 로고    scopus 로고
    • Effects of intensive glucose lowering in type 2 diabetes
    • The Action to Control Cardiovascular Risk in Diabetes Study Group.
    • The Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008; 358: 2545-2559.
    • (2008) N Engl J Med , vol.358 , pp. 2545-2559
  • 113
    • 77955585592 scopus 로고    scopus 로고
    • Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial
    • The ACCORD trial group.
    • Ismail-Beigi F, Craven T, Banerji MA, et al, the ACCORD trial group. Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. Lancet 2010; 376: 419-430.
    • (2010) Lancet , vol.376 , pp. 419-430
    • Ismail-Beigi, F.1    Craven, T.2    Banerji, M.A.3
  • 114
    • 45149133036 scopus 로고    scopus 로고
    • Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
    • The ADVANCE Collaborative Group.
    • The ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008; 358: 2560-2572.
    • (2008) N Engl J Med , vol.358 , pp. 2560-2572
  • 115
    • 58149389215 scopus 로고    scopus 로고
    • Glucose control and vascular complications in veterans with type 2 diabetes
    • the VADT investigators.
    • Duckworth W, Abraira C, Moritz T, et al, the VADT investigators. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009; 360: 129-139.
    • (2009) N Engl J Med , vol.360 , pp. 129-139
    • Duckworth, W.1    Abraira, C.2    Moritz, T.3
  • 116
    • 0242269000 scopus 로고    scopus 로고
    • The treat-to-target trial, Randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients.
    • Riddle M, Rosenstock J, Gerich J. The treat-to-target trial. Randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients. Diabetes Care 2003; 26: 3080-3086.
    • (2003) Diabetes Care , vol.26 , pp. 3080-3086
    • Riddle, M.1    Rosenstock, J.2    Gerich, J.3
  • 117
    • 48149095259 scopus 로고    scopus 로고
    • The A1C-Derived Average Glucose (ADAG) Study Group. Translating the A1C assay into estimated average glucose values
    • Nathan DM, Kuenen J, Borg R, et al, the A1C-Derived Average Glucose (ADAG) Study Group. Translating the A1C assay into estimated average glucose values. Diabetes Care 2008; 31: 1-6.
    • (2008) Diabetes Care , vol.31 , pp. 1-6
    • Nathan, D.M.1    Kuenen, J.2    Borg, R.3
  • 118
    • 84898545029 scopus 로고    scopus 로고
    • International Diabetes Federation. Position statement: bariatric surgical and procedural interventions in the treatment of obese patients with type 2 diabetes. Brussels: International Diabetes Federation
    • International Diabetes Federation. Position statement: bariatric surgical and procedural interventions in the treatment of obese patients with type 2 diabetes. Brussels: International Diabetes Federation; 2011. http://www.idf.org/ webdata/docs/IDF-Position-Statement-Bariatric-Surgery.pdf.
    • (2011)
  • 119
    • 84898541443 scopus 로고    scopus 로고
    • The National Collaborating Centre for Chronic Conditions. Type 2 diabetes: the management of type 2 diabetes. NICE clinical guideline 87. London: Royal College of Physicians
    • The National Collaborating Centre for Chronic Conditions. Type 2 diabetes: the management of type 2 diabetes. NICE clinical guideline 87. London: Royal College of Physicians; 2009. http:// www.nice.org.uk/nicemedia/pdf/CG87NICEGuideline.pdf.
    • (2009)
  • 120
    • 65749098338 scopus 로고    scopus 로고
    • Canadian Diabetes Association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada
    • Canadian Diabetes Association Clinical Practice Guidelines Expert Committee.
    • Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes 2008; 32: S95-S98. http:// www.diabetes.ca.
    • (2008) Can J Diabetes , vol.32
  • 121
    • 84898549271 scopus 로고    scopus 로고
    • National evidence based guideline for blood glucose control in type 2 diabetes. Canberra: Diabetes Australia and the NHMRC
    • Colagiuri S, Dickinson S, Girgis S, et al. National evidence based guideline for blood glucose control in type 2 diabetes. Canberra: Diabetes Australia and the NHMRC; 2009. http:// www.nhmrc.gov.au/guidelines/publications/di19.
    • (2009)
    • Colagiuri, S.1    Dickinson, S.2    Girgis, S.3
  • 122
    • 0000656517 scopus 로고    scopus 로고
    • Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus
    • Sacks DB, Bruns DE, Goldstein DE, et al. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Diabetes Care 2002; 25: 750-786.
    • (2002) Diabetes Care , vol.25 , pp. 750-786
    • Sacks, D.B.1    Bruns, D.E.2    Goldstein, D.E.3
  • 123
    • 84898541656 scopus 로고    scopus 로고
    • National Diabetes Information Clearinghouse. The A1C test and diabetes. NIH Publication No.: 11-7816. Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health
    • National Diabetes Information Clearinghouse. The A1C test and diabetes. NIH Publication No.: 11-7816. Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health; 2011.
    • (2011)
  • 124
    • 80052695368 scopus 로고    scopus 로고
    • Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus
    • Report of a World Health Organization Consultation.
    • Report of a World Health Organization Consultation. Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus. Diabetes Res Clin Pract 2011; 93: 299-309.
    • (2011) Diabetes Res Clin Pract , vol.93 , pp. 299-309
  • 125
    • 0029094533 scopus 로고
    • The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the Diabetes Control and Complications Trial
    • The Diabetes Control and Complications Trial Research Group.
    • The Diabetes Control and Complications Trial Research Group. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the Diabetes Control and Complications Trial. Diabetes 1995; 44: 968-983.
    • (1995) Diabetes , vol.44 , pp. 968-983
  • 126
    • 0034641568 scopus 로고    scopus 로고
    • Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study
    • Stratton IM, Adler AI, Neil HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000; 321: 405-412.
    • (2000) BMJ , vol.321 , pp. 405-412
    • Stratton, I.M.1    Adler, A.I.2    Neil, H.A.3
  • 127
    • 45149131667 scopus 로고    scopus 로고
    • Effects of intensive glucose lowering in type 2 diabetes
    • The Action to Control Cardiovascular Risk in Diabetes Study Group.
    • The Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008; 358: 2545-2559.
    • (2008) N Engl J Med , vol.358 , pp. 2545-2559
  • 128
    • 45149133036 scopus 로고    scopus 로고
    • Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
    • The ADVANCE Collaborative Group.
    • The ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008; 358: 2560-2572.
    • (2008) N Engl J Med , vol.358 , pp. 2560-2572
  • 129
    • 58149389215 scopus 로고    scopus 로고
    • Glucose control and vascular complications in veterans with type 2 diabetes
    • the VADT investigators.
    • Duckworth W, Abraira C, Moritz T, et al, the VADT investigators. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009; 360: 129-139.
    • (2009) N Engl J Med , vol.360 , pp. 129-139
    • Duckworth, W.1    Abraira, C.2    Moritz, T.3
  • 130
    • 0031812999 scopus 로고    scopus 로고
    • Preparation of a candidate primary reference material for the international standardisation of HbA1c determinations
    • Finke A, Kobold U, Hoelzel W, et al. Preparation of a candidate primary reference material for the international standardisation of HbA1c determinations. Clin Chem Lab Med 1998; 36: 299-308.
    • (1998) Clin Chem Lab Med , vol.36 , pp. 299-308
    • Finke, A.1    Kobold, U.2    Hoelzel, W.3
  • 131
    • 34548493657 scopus 로고    scopus 로고
    • Consensus statement on the worldwide standardisation of the HbA1c measurement
    • American Diabetes Association, European Association for the Study of Diabetes, International Federation of Clinical Chemistry and Laboratory Medicine, International Diabetes Federation.
    • American Diabetes Association, European Association for the Study of Diabetes, International Federation of Clinical Chemistry and Laboratory Medicine, International Diabetes Federation. Consensus statement on the worldwide standardisation of the HbA1c measurement. Diabetologia 2007; 50: 2042-2043.
    • (2007) Diabetologia , vol.50 , pp. 2042-2043
  • 132
    • 77957750912 scopus 로고    scopus 로고
    • 2010 consensus statement on the worldwide standardization of the hemoglobin A(1c) measurement
    • Hanas R, John G. 2010 consensus statement on the worldwide standardization of the hemoglobin A(1c) measurement. Diabetes Res Clin Pr 2010; 90: 228-230.
    • (2010) Diabetes Res Clin Pr , vol.90 , pp. 228-230
    • Hanas, R.1    John, G.2
  • 133
    • 48149095259 scopus 로고    scopus 로고
    • Translating the A1C assay into estimated average glucose values
    • Nathan DM, Kuenen J, Borg R, et al. Translating the A1C assay into estimated average glucose values. Diabetes Care 2008; 31: 1473-1478.
    • (2008) Diabetes Care , vol.31 , pp. 1473-1478
    • Nathan, D.M.1    Kuenen, J.2    Borg, R.3
  • 134
    • 0041866808 scopus 로고    scopus 로고
    • Hemoglobin variants and hemoglobin A1c analysis: problem solved?
    • Sacks DB. Hemoglobin variants and hemoglobin A1c analysis: problem solved? Clin Chem 2003; 49: 1245-1247.
    • (2003) Clin Chem , vol.49 , pp. 1245-1247
    • Sacks, D.B.1
  • 135
    • 58149165365 scopus 로고    scopus 로고
    • Red cell life span heterogeneity in hematologically normal people is sufficient to alter HbA1c
    • Cohen RM, Franco RS, Khera PK, et al. Red cell life span heterogeneity in hematologically normal people is sufficient to alter HbA1c. Blood 2008; 112: 4284-4291.
    • (2008) Blood , vol.112 , pp. 4284-4291
    • Cohen, R.M.1    Franco, R.S.2    Khera, P.K.3
  • 136
    • 60049099028 scopus 로고    scopus 로고
    • When HbA1c for a patient does not reflect glycaemic control indicated by plasma glucose monitoring
    • Manley SE, Moore S, Smith JM, et al. When HbA1c for a patient does not reflect glycaemic control indicated by plasma glucose monitoring. Diabet Med 2008; 25: 256.
    • (2008) Diabet Med , vol.25 , pp. 256
    • Manley, S.E.1    Moore, S.2    Smith, J.M.3
  • 137
    • 77953032144 scopus 로고    scopus 로고
    • Association between iron deficiency and A1C levels among adults without diabetes in the National Health and Nutrition Examination Survey, 1999-2006
    • Kim C, Bullard KM, Herman WH, et al. Association between iron deficiency and A1C levels among adults without diabetes in the National Health and Nutrition Examination Survey, 1999-2006. Diabetes Care 2010; 33: 780-785.
    • (2010) Diabetes Care , vol.33 , pp. 780-785
    • Kim, C.1    Bullard, K.M.2    Herman, W.H.3
  • 138
    • 84898543244 scopus 로고    scopus 로고
    • Raised fetal haemoglobin in patients with diabetes and other coexisting illnesses
    • Border DK, Round RA, Mason CL, et al. Raised fetal haemoglobin in patients with diabetes and other coexisting illnesses. Diabet Med 2011; 28: S164 P438.
    • (2011) Diabet Med , vol.28
    • Border, D.K.1    Round, R.A.2    Mason, C.L.3
  • 139
    • 84898540064 scopus 로고    scopus 로고
    • Guidelines for the clinical management of thalassaemia 2nd edition revised 2008. Cyprus: Thalassaemia International Federation
    • Cappellini M-D, Cohen A, Eleftheriou A, et al. Guidelines for the clinical management of thalassaemia 2nd edition revised 2008. Cyprus: Thalassaemia International Federation; 2008.
    • (2008)
    • Cappellini, M-D.1    Cohen, A.2    Eleftheriou, A.3
  • 140
    • 78149387556 scopus 로고    scopus 로고
    • Spuriously high HbA1c due to the presence of haemoglobin Raleigh: a case report and review of the literature
    • 23
    • Vandewiele A, Genbrugge K, Delanghe J. Spuriously high HbA1c due to the presence of haemoglobin Raleigh: a case report and review of the literature. J Acta Clin Belg 2010; 65: 336-340 23.
    • (2010) J Acta Clin Belg , vol.65 , pp. 336-340
    • Vandewiele, A.1    Genbrugge, K.2    Delanghe, J.3
  • 141
    • 84898548674 scopus 로고    scopus 로고
    • Rare, 'fast' haemoglobin variants may interfere with HbA1c measurement using ion exchange high performance liquid chromatography: implications for diagnosis of diabetes
    • Abstract No, A-1091. In press
    • Misra S, Hancock MR, Roper D, et al. Rare, 'fast' haemoglobin variants may interfere with HbA1c measurement using ion exchange high performance liquid chromatography: implications for diagnosis of diabetes. EASD 2012; Abstract No: A-1091. In press.
    • (2012) EASD
    • Misra, S.1    Hancock, M.R.2    Roper, D.3
  • 142
    • 77955156159 scopus 로고    scopus 로고
    • Serum fructosamine versus glycosylated hemoglobin as an index of glycemic control, hospitalization, and infection in diabetic hemodialysis patients
    • Mittman N, Desiraju B, Fazil I, et al. Serum fructosamine versus glycosylated hemoglobin as an index of glycemic control, hospitalization, and infection in diabetic hemodialysis patients. Kidney Int Suppl 2010; 117: S41-S45.
    • (2010) Kidney Int Suppl , vol.117
    • Mittman, N.1    Desiraju, B.2    Fazil, I.3
  • 143
    • 84898538714 scopus 로고    scopus 로고
    • When fructosamine results do not reflect glycaemic control indicated by other markers?
    • S154 P390
    • Manley SE, Gomes AN, McKnight JA, et al. When fructosamine results do not reflect glycaemic control indicated by other markers? Diabet Med 2009; 26: S154 P390.
    • (2009) Diabet Med , vol.26
    • Manley, S.E.1    Gomes, A.N.2    McKnight, J.A.3
  • 144
    • 84898546771 scopus 로고    scopus 로고
    • How is fructosamine affected by urinary albumin excretion?
    • SA2195-PO
    • Manley SE, Round RA, Nightingale PG, et al. How is fructosamine affected by urinary albumin excretion? Diabetes 2011; 60:SA2195-PO.
    • (2011) Diabetes , vol.60
    • Manley, S.E.1    Round, R.A.2    Nightingale, P.G.3
  • 145
    • 54849147700 scopus 로고    scopus 로고
    • Continuous glucose monitoring and intensive treatment of type 1 diabetes
    • The Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group
    • The Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, Tamborlane WV, Beck RW, Bode BW, Buckingham B, et al. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med 2008; 359: 1464-1476.
    • (2008) N Engl J Med , vol.359 , pp. 1464-1476
    • Tamborlane, W.V.1    Beck, R.W.2    Bode, B.W.3    Buckingham, B.4
  • 146
    • 56949088690 scopus 로고    scopus 로고
    • Continuous glucose monitoring in type 2 diabetes
    • Harman-Boehm I. Continuous glucose monitoring in type 2 diabetes. Diabetes Res Clin Pract 2008; 82: S118-S121.
    • (2008) Diabetes Res Clin Pract , vol.82
    • Harman-Boehm, I.1
  • 147
    • 1042302779 scopus 로고    scopus 로고
    • Bedside blood glucose monitoring in hospitals
    • American Diabetes Association.
    • American Diabetes Association. Bedside blood glucose monitoring in hospitals. Diabetes Care 2004; 27: S104.
    • (2004) Diabetes Care , vol.27
  • 148
    • 55549137361 scopus 로고    scopus 로고
    • Self-monitoring of blood glucose in type 2 diabetes: an inter-country comparison
    • Bot S, Davis TME, Davis WA, et al. Self-monitoring of blood glucose in type 2 diabetes: an inter-country comparison. Diabetes Res Clin Pract 2008; 82: e15-e18.
    • (2008) Diabetes Res Clin Pract , vol.82
    • Bot, S.1    Davis, T.M.E.2    Davis, W.A.3
  • 149
    • 84898544026 scopus 로고    scopus 로고
    • International Diabetes Federation. Self-monitoring of blood glucose in non-insulin treated type 2 diabetes. Brussels: International Diabetes Federation
    • International Diabetes Federation. Self-monitoring of blood glucose in non-insulin treated type 2 diabetes. Brussels: International Diabetes Federation; 2009.
    • (2009)
  • 150
    • 84898549353 scopus 로고    scopus 로고
    • The National Collaborating Centre for Chronic Conditions. Type 2 diabetes: the management of type 2 diabetes. NICE clinical guideline 87. London: Royal College of Physicians
    • The National Collaborating Centre for Chronic Conditions. Type 2 diabetes: the management of type 2 diabetes. NICE clinical guideline 87. London: Royal College of Physicians; 2009. http:// www.nice.org.uk/nicemedia/pdf/CG87NICEGuideline.pdf.
    • (2009)
  • 151
    • 65749098338 scopus 로고    scopus 로고
    • Canadian Diabetes Association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada
    • Canadian Diabetes Association Clinical Practice Guidelines Expert Committee.
    • Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes 2008; 32: S95-S98. http:// www.diabetes.ca.
    • (2008) Can J Diabetes , vol.32
  • 152
    • 84855185039 scopus 로고    scopus 로고
    • Standards of medical care in diabetes
    • American Diabetes Association.
    • American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 2012; 35: S11-S63.
    • (2012) Diabetes Care , vol.35
  • 153
    • 84898542689 scopus 로고    scopus 로고
    • National evidence based guideline for blood glucose control in type 2 diabetes. Canberra: Diabetes Australia and the NHMRC
    • Colagiuri S, Dickinson S, Girgis S, et al. National evidence based guideline for blood glucose control in type 2 diabetes. Canberra: Diabetes Australia and the NHMRC; 2009. http:// www.nhmrc.gov.au/guidelines/publications/di19.
    • (2009)
    • Colagiuri, S.1    Dickinson, S.2    Girgis, S.3
  • 154
    • 29144453326 scopus 로고    scopus 로고
    • Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
    • The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group.
    • The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005; 353: 2643-2653.
    • (2005) N Engl J Med , vol.353 , pp. 2643-2653
  • 155
    • 0029147687 scopus 로고
    • Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study
    • Ohkubo Y, Kishikawa H, Araki E, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 1995; 28: 103-117.
    • (1995) Diabetes Res Clin Pract , vol.28 , pp. 103-117
    • Ohkubo, Y.1    Kishikawa, H.2    Araki, E.3
  • 156
    • 47749083574 scopus 로고    scopus 로고
    • Self-monitoring of blood glucose levels in patients with type 2 diabetes mellitus not taking insulin: a meta-analysis
    • Towfigh A, Romanova M, Weinreb JE, et al. Self-monitoring of blood glucose levels in patients with type 2 diabetes mellitus not taking insulin: a meta-analysis. Am J Manag Care 2008; 14: 468-475.
    • (2008) Am J Manag Care , vol.14 , pp. 468-475
    • Towfigh, A.1    Romanova, M.2    Weinreb, J.E.3
  • 157
    • 33746615495 scopus 로고    scopus 로고
    • Longitudinal study of new and prevalent use of self-monitoring of blood glucose
    • Karter AJ, Parker MM, Moffet HH, et al. Longitudinal study of new and prevalent use of self-monitoring of blood glucose. Diabetes Care 2006; 29: 1757-1763.
    • (2006) Diabetes Care , vol.29 , pp. 1757-1763
    • Karter, A.J.1    Parker, M.M.2    Moffet, H.H.3
  • 158
    • 33846811037 scopus 로고    scopus 로고
    • Does self-monitoring of blood glucose improve outcome in type 2 diabetes? The Fremantle diabetes study.
    • Davis WA, Bruce DG, Davis ME. Does self-monitoring of blood glucose improve outcome in type 2 diabetes? The Fremantle diabetes study. Diabetologia 2007; 50: 510-515.
    • (2007) Diabetologia , vol.50 , pp. 510-515
    • Davis, W.A.1    Bruce, D.G.2    Davis, M.E.3
  • 159
    • 34447636939 scopus 로고    scopus 로고
    • Impact of self monitoring of blood glucose in the management of patients with noninsulin treated diabetes: open parallel group randomised trial
    • Farmer A, Wade A, Goyder E, et al. Impact of self monitoring of blood glucose in the management of patients with noninsulin treated diabetes: open parallel group randomised trial. BMJ 2007; 335: 132.
    • (2007) BMJ , vol.335 , pp. 132
    • Farmer, A.1    Wade, A.2    Goyder, E.3
  • 160
    • 44449096635 scopus 로고    scopus 로고
    • Cost effectiveness of self monitoring of blood glucose in patients with non-insulin treated type 2 diabetes: economic evaluation of data from the DiGEM trial
    • Simon J, Gray A, Clarke P, et al. Cost effectiveness of self monitoring of blood glucose in patients with non-insulin treated type 2 diabetes: economic evaluation of data from the DiGEM trial. BMJ 2008; 336: 1177-1180.
    • (2008) BMJ , vol.336 , pp. 1177-1180
    • Simon, J.1    Gray, A.2    Clarke, P.3
  • 161
    • 44449103216 scopus 로고    scopus 로고
    • Efficacy of self monitoring of blood glucose in patients with newly diagnosed type 2 diabetes (ESMON study): randomised controlled trial
    • the ESMON Study Group.
    • O'Kane MJ, Bunting B, Copeland M, et al, the ESMON Study Group. Efficacy of self monitoring of blood glucose in patients with newly diagnosed type 2 diabetes (ESMON study): randomised controlled trial. BMJ 2008; 336: 1174-1177.
    • (2008) BMJ , vol.336 , pp. 1174-1177
    • O'Kane, M.J.1    Bunting, B.2    Copeland, M.3
  • 162
    • 55449121471 scopus 로고    scopus 로고
    • The efficacy of selfmonitoring of blood glucose in the management of patients with type 2 diabetes treated with a gliclazide modified release-based regime. A multicentre, randomized, parallelgroup, 6-month evaluation (DINAMIC 1 study).
    • Barnett AH, Krentz AJ, Strojek K, et al. The efficacy of selfmonitoring of blood glucose in the management of patients with type 2 diabetes treated with a gliclazide modified release-based regimen. A multicentre, randomized, parallelgroup, 6-month evaluation (DINAMIC 1 study). Diabetes Obes Metab 2008; 10: 1239-1247.
    • (2008) Diabetes Obes Metab , vol.10 , pp. 1239-1247
    • Barnett, A.H.1    Krentz, A.J.2    Strojek, K.3
  • 163
    • 84898549715 scopus 로고    scopus 로고
    • International Diabetes Federation. 2011 Guideline for management of post meal glucose in diabetes. Brussels: International Diabetes Federation
    • International Diabetes Federation. 2011 Guideline for management of post meal glucose in diabetes. Brussels: International Diabetes Federation; 2011. http://www.idf.org.
    • (2011)
  • 164
    • 53349100531 scopus 로고    scopus 로고
    • Self-monitoring of blood glucose changed non-insulin treated type 2 diabetes patients' beliefs about diabetes and self-monitoring in a randomised trial
    • French DP, Wade A, Yudkin P, et al. Self-monitoring of blood glucose changed non-insulin treated type 2 diabetes patients' beliefs about diabetes and self-monitoring in a randomised trial. Diabetic Med 2008; 25: 1218-1228.
    • (2008) Diabetic Med , vol.25 , pp. 1218-1228
    • French, D.P.1    Wade, A.2    Yudkin, P.3
  • 165
    • 0036834583 scopus 로고    scopus 로고
    • Meal-related structured self-monitoring of blood glucose: effect on diabetes control in non-insulin-treated type 2 diabetic patients
    • Schwedes U, Siebolds M, Mertes G. Meal-related structured self-monitoring of blood glucose: effect on diabetes control in non-insulin-treated type 2 diabetic patients. Diabetes Care 2002; 25: 1928-1932.
    • (2002) Diabetes Care , vol.25 , pp. 1928-1932
    • Schwedes, U.1    Siebolds, M.2    Mertes, G.3
  • 166
    • 34548616859 scopus 로고    scopus 로고
    • Self monitoring of blood glucose in type 2 diabetes: longitudinal qualitative study of patients' perspectives
    • Peel E, Douglas M, Lawton J. Self monitoring of blood glucose in type 2 diabetes: longitudinal qualitative study of patients' perspectives. BMJ 2007; 335: 493.
    • (2007) BMJ , vol.335 , pp. 493
    • Peel, E.1    Douglas, M.2    Lawton, J.3
  • 167
    • 19944412732 scopus 로고    scopus 로고
    • Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin: a systematic review
    • Welschen LMC, Bloemendal E, Nijpels G, et al. Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin: a systematic review. Diabetes Care 2005; 28: 1510-1517.
    • (2005) Diabetes Care , vol.28 , pp. 1510-1517
    • Welschen, L.M.C.1    Bloemendal, E.2    Nijpels, G.3
  • 168
    • 84898548099 scopus 로고    scopus 로고
    • The National Collaborating Centre for Chronic Conditions. Type 2 diabetes: the management of type 2 diabetes. NICE clinical guideline 87. London: Royal College of Physicians
    • The National Collaborating Centre for Chronic Conditions. Type 2 diabetes: the management of type 2 diabetes. NICE clinical guideline 87. London: Royal College of Physicians; 2009. http://www.nice.org.uk/nicemedia/pdf/ CG87NICEGuideline.pdf.
    • (2009)
  • 169
    • 65749098338 scopus 로고    scopus 로고
    • Canadian Diabetes Association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada
    • Canadian Diabetes Association Clinical Practice Guidelines Expert Committee.
    • Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes 2008; 32: S95-S98. http:// www.diabetes.ca.
    • (2008) Can J Diabetes , vol.32
  • 170
    • 84855185039 scopus 로고    scopus 로고
    • Standards of medical care in diabetes
    • American Diabetes Association.
    • American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 2012; 35: S11-S63.
    • (2012) Diabetes Care , vol.35
  • 171
    • 84898548565 scopus 로고    scopus 로고
    • National evidence based guideline for blood glucose control in type 2 diabetes. Canberra: Diabetes Australia and the NHMRC
    • Colagiuri S, Dickinson S, Girgis S, et al. National evidence based guideline for blood glucose control in type 2 diabetes. Canberra: Diabetes Australia and the NHMRC; 2009. http:// www.nhmrc.gov.au/guidelines/publications/di19.
    • (2009)
    • Colagiuri, S.1    Dickinson, S.2    Girgis, S.3
  • 172
    • 84856740961 scopus 로고    scopus 로고
    • Oral pharmacologic treatment of type 2 diabetes mellitus: a clinical practice guideline from the American College of Physicians
    • the Clinical Guidelines Committee of the American College of Physicians.
    • Qaseem A, Humphrey LL, Sweet DE, et al, the Clinical Guidelines Committee of the American College of Physicians. Oral pharmacologic treatment of type 2 diabetes mellitus: a clinical practice guideline from the American College of Physicians. Ann Intern Med 2012; 156: 218-231.
    • (2012) Ann Intern Med , vol.156 , pp. 218-231
    • Qaseem, A.1    Humphrey, L.L.2    Sweet, D.E.3
  • 173
    • 84898543457 scopus 로고    scopus 로고
    • International Diabetes Federation. Global guideline for type 2 diabetes. Brussels: International Diabetes Federation
    • International Diabetes Federation. Global guideline for type 2 diabetes. Brussels: International Diabetes Federation; 2005. http://www.idf.org/webdata/docs/IDF%20GGT2D.pdf.
    • (2005)
  • 174
    • 79952695485 scopus 로고    scopus 로고
    • Highlights from "Italian Standards of care for Diabetes Mellitus 2009- 2010"
    • Società Italiana di Diabetologia-Associazione Medici Diabetologi (SID-AMD) working group on the Standards of Care for Diabetes.
    • Bruno G, De Micheli A, Frontoni S, et al, Società Italiana di Diabetologia-Associazione Medici Diabetologi (SID-AMD) working group on the Standards of Care for Diabetes. Highlights from "Italian Standards of care for Diabetes Mellitus 2009- 2010". Nutr Metab Cardiovasc Dis 2011; 21: 302-314.
    • (2011) Nutr Metab Cardiovasc Dis , vol.21 , pp. 302-314
    • Bruno, G.1    De Micheli, A.2    Frontoni, S.3
  • 175
    • 84864285795 scopus 로고    scopus 로고
    • Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association and the European Association for the Study of Diabetes.
    • Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 2012; 55: 1577-1596.
    • (2012) Diabetologia , vol.55 , pp. 1577-1596
    • Inzucchi, S.E.1    Bergenstal, R.M.2    Buse, J.B.3
  • 176
    • 79955752170 scopus 로고    scopus 로고
    • Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations
    • Bennett WL, Maruthur NM, Singh S, et al. Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations. Ann Intern Med 2011; 154: 602-613.
    • (2011) Ann Intern Med , vol.154 , pp. 602-613
    • Bennett, W.L.1    Maruthur, N.M.2    Singh, S.3
  • 177
    • 0032511566 scopus 로고    scopus 로고
    • Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)
    • UK Prospective Diabetes Study Group.
    • UK Prospective Diabetes Study Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998; 352: 854-865.
    • (1998) Lancet , vol.352 , pp. 854-865
  • 178
    • 78851470539 scopus 로고    scopus 로고
    • Effect of metformin on cardiovascular events and mortality: a metaanalysis of randomized clinical trials
    • Lamanna C, Monami M, Marchionni N, et al. Effect of metformin on cardiovascular events and mortality: a metaanalysis of randomized clinical trials. Diabetes Obes Metab 2011; 13: 221-228.
    • (2011) Diabetes Obes Metab , vol.13 , pp. 221-228
    • Lamanna, C.1    Monami, M.2    Marchionni, N.3
  • 179
    • 0032511583 scopus 로고    scopus 로고
    • Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
    • UK Prospective Diabetes Study Group.
    • UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-853.
    • (1998) Lancet , vol.352 , pp. 837-853
  • 180
    • 45149133036 scopus 로고    scopus 로고
    • Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
    • The ADVANCE Collaborative Group.
    • The ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008; 358: 2560-2572.
    • (2008) N Engl J Med , vol.358 , pp. 2560-2572
  • 181
    • 11844294865 scopus 로고    scopus 로고
    • a-glucosidase inhibitors for patients with type 2 diabetes: results from a Cochrane systematic review and meta-analysis
    • van de Laar FA, Lucassen PL, Akkermans RP, et al. a-glucosidase inhibitors for patients with type 2 diabetes: results from a Cochrane systematic review and meta-analysis. Diabetes Care 2005; 28: 154-163.
    • (2005) Diabetes Care , vol.28 , pp. 154-163
    • Van de Laar, F.A.1    Lucassen, P.L.2    Akkermans, R.P.3
  • 182
    • 0346727578 scopus 로고    scopus 로고
    • Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies
    • Hanefeld M, Cagatay M, Petrowitsch T, et al. Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies. Eur Heart J 2004; 25: 10-16.
    • (2004) Eur Heart J , vol.25 , pp. 10-16
    • Hanefeld, M.1    Cagatay, M.2    Petrowitsch, T.3
  • 183
    • 34447267513 scopus 로고    scopus 로고
    • Efficacy and safety of incretin therapy in type 2 diabetes: systematic review and metaanalysis
    • Amori RE, Lau J, Pittas AG. Efficacy and safety of incretin therapy in type 2 diabetes: systematic review and metaanalysis. JAMA 2007; 298(2): 194-206.
    • (2007) JAMA , vol.298 , Issue.2 , pp. 194-206
    • Amori, R.E.1    Lau, J.2    Pittas, A.G.3
  • 184
    • 33845405222 scopus 로고    scopus 로고
    • Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy
    • Kahn SE, Haffner SM, Heise MA, et al. Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. N Engl J Med 2006; 355: 2427-2443.
    • (2006) N Engl J Med , vol.355 , pp. 2427-2443
    • Kahn, S.E.1    Haffner, S.M.2    Heise, M.A.3
  • 185
    • 34250212715 scopus 로고    scopus 로고
    • Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes
    • Nissen SE, Wolski K. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med 2007; 356: 2457-2471.
    • (2007) N Engl J Med , vol.356 , pp. 2457-2471
    • Nissen, S.E.1    Wolski, K.2
  • 186
    • 34548580881 scopus 로고    scopus 로고
    • Long-term risk of cardiovascular events with rosiglitazone: a meta-analysis
    • Singh S, Loke YK, Furberg CD. Long-term risk of cardiovascular events with rosiglitazone: a meta-analysis. JAMA 2007; 298: 1189-1195.
    • (2007) JAMA , vol.298 , pp. 1189-1195
    • Singh, S.1    Loke, Y.K.2    Furberg, C.D.3
  • 187
    • 67149146438 scopus 로고    scopus 로고
    • Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial
    • the RECORD Study Group.
    • Home PD, Pocock SJ, Beck-Nielsen H, et al, the RECORD Study Group. Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial. Lancet 2009; 373: 2125-2135.
    • (2009) Lancet , vol.373 , pp. 2125-2135
    • Home, P.D.1    Pocock, S.J.2    Beck-Nielsen, H.3
  • 188
    • 26244453309 scopus 로고    scopus 로고
    • Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive (PROspective pioglitAzone Clinical Trial in macrovascular Events): a randomized controlled trial
    • Dormandy JA, Charbonnel B, Eckland DJA, et al. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive (PROspective pioglitAzone Clinical Trial in macrovascular Events): a randomized controlled trial. Lancet 2005; 366: 1279-1289.
    • (2005) Lancet , vol.366 , pp. 1279-1289
    • Dormandy, J.A.1    Charbonnel, B.2    Eckland, D.J.A.3
  • 189
    • 33745000699 scopus 로고    scopus 로고
    • Triple therapy in type 2 diabetes: insulin glargine or rosiglitazone added to combination therapy of sulfonylurea plus metformin in insulin-naive patients
    • Rosenstock J, Sugimoto D, Strange P, et al. Triple therapy in type 2 diabetes: insulin glargine or rosiglitazone added to combination therapy of sulfonylurea plus metformin in insulin-naive patients. Diabetes Care 2006; 29: 554-559.
    • (2006) Diabetes Care , vol.29 , pp. 554-559
    • Rosenstock, J.1    Sugimoto, D.2    Strange, P.3
  • 190
    • 84928701920 scopus 로고    scopus 로고
    • Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus
    • Siebenhofer A, Plank J, Berghold A, et. Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus. Cochrane DB Syst Rev 2009; CD003287.
    • (2009) Cochrane DB Syst Rev
    • Siebenhofer, A.1    Plank, J.2    Berghold, A.3
  • 191
    • 77950283292 scopus 로고    scopus 로고
    • Long acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus
    • Horvath K, Jeitler K, Berghold A, et al. Long acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus. Cochrane DB Syst Rev 2009; CD005613.
    • (2009) Cochrane DB Syst Rev
    • Horvath, K.1    Jeitler, K.2    Berghold, A.3
  • 192
    • 84898543726 scopus 로고    scopus 로고
    • National Institute for Clinical Excellence. Guidance on the use of long-acting insulin analogues for the treatment of diabetes - insulin glargine. NICE Technology Appraisal Guidance No. 53. London: National Institute for Clinical Excellence
    • National Institute for Clinical Excellence. Guidance on the use of long-acting insulin analogues for the treatment of diabetes - insulin glargine. NICE Technology Appraisal Guidance No. 53. London: National Institute for Clinical Excellence; 2002. http://www.nice.org.uk.
    • (2002)
  • 193
    • 79954583330 scopus 로고    scopus 로고
    • Treatment regimens with insulin analogues and haemoglobin A1c target of >7% in type 2 diabetes: a systematic review
    • Giugliano D, Maiorino MI, Bellastela G, et al. Treatment regimens with insulin analogues and haemoglobin A1c target of >7% in type 2 diabetes: a systematic review. Diab Res Clin Pr 2011; 92: 1-10.
    • (2011) Diab Res Clin Pr , vol.92 , pp. 1-10
    • Giugliano, D.1    Maiorino, M.I.2    Bellastela, G.3
  • 194
    • 16644372491 scopus 로고    scopus 로고
    • Insulin monotherapy versus combinations of insulin with oral hypoglycaemic agents in patients with type 2 diabetes mellitus
    • Goudswaard AN, Furlong NJ, Valk GD, et al. Insulin monotherapy versus combinations of insulin with oral hypoglycaemic agents in patients with type 2 diabetes mellitus. Cochrane DB Syst Rev 2004; 4: CD003418.
    • (2004) Cochrane DB Syst Rev , vol.4
    • Goudswaard, A.N.1    Furlong, N.J.2    Valk, G.D.3
  • 195
    • 0029147687 scopus 로고
    • Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulindependent diabetes mellitus: a randomized prospective 6-year study
    • Ohkubo Y, Kishikawa H, Araki E, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulindependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 1995; 28: 103-117.
    • (1995) Diabetes Res Clin Pract , vol.28 , pp. 103-117
    • Ohkubo, Y.1    Kishikawa, H.2    Araki, E.3
  • 196
    • 0042824199 scopus 로고    scopus 로고
    • Continuous subcutaneous insulin therapy and multiple daily injection therapy are equally effective in type 2 diabetes
    • Raskin P, Bode BW, Marks JB, et al. Continuous subcutaneous insulin therapy and multiple daily injection therapy are equally effective in type 2 diabetes. Diabetes Care 2003; 26: 2598-2603.
    • (2003) Diabetes Care , vol.26 , pp. 2598-2603
    • Raskin, P.1    Bode, B.W.2    Marks, J.B.3
  • 197
    • 7344263454 scopus 로고    scopus 로고
    • Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes (UKPDS 40)
    • UK Prospective Diabetes Study Group.
    • UK Prospective Diabetes Study Group. Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes (UKPDS 40). BMJ 1998; 317: 720-726.
    • (1998) BMJ , vol.317 , pp. 720-726
  • 198
    • 84898545697 scopus 로고    scopus 로고
    • The National Collaborating Centre for Chronic Conditions. Type 2 diabetes: the management of type 2 diabetes. NICE clinical guideline 87. London: Royal College of Physicians
    • The National Collaborating Centre for Chronic Conditions. Type 2 diabetes: the management of type 2 diabetes. NICE clinical guideline 87. London: Royal College of Physicians; 2009. http://www.nice.org.uk/nicemedia/pdf/ CG87NICEGuideline.pdf.
    • (2009)
  • 199
    • 65749098338 scopus 로고    scopus 로고
    • Canadian Diabetes Association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada
    • Canadian Diabetes Association Clinical Practice Guidelines Expert Committee.
    • Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes 2008; 32: S95-S98. http:// www.diabetes.ca.
    • (2008) Can J Diabetes , vol.32
  • 200
    • 84898547841 scopus 로고    scopus 로고
    • National Vascular Disease Prevention Alliance. Evidencebased practice guidelines for the management of absolute cardiovascular disease risk. Canberra: NHMRC
    • National Vascular Disease Prevention Alliance. Evidencebased practice guidelines for the management of absolute cardiovascular disease risk. Canberra: NHMRC; 2012.
    • (2012)
  • 201
    • 67650082354 scopus 로고    scopus 로고
    • Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies
    • Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 2009; 338: b1665.
    • (2009) BMJ , vol.338
    • Law, M.R.1    Morris, J.K.2    Wald, N.J.3
  • 202
    • 79959504988 scopus 로고    scopus 로고
    • Blood pressure targets in subjects with type 2 diabetes mellitus/impaired fasting glucose: observations from traditional and bayesian randomeffects meta-analyses of randomized trials
    • Bangalore S, Kumar S, Lobach I, et al. Blood pressure targets in subjects with type 2 diabetes mellitus/impaired fasting glucose: observations from traditional and bayesian randomeffects meta-analyses of randomized trials. Circulation 2011; 123: 2799-2810.
    • (2011) Circulation , vol.123 , pp. 2799-2810
    • Bangalore, S.1    Kumar, S.2    Lobach, I.3
  • 203
    • 79958769725 scopus 로고    scopus 로고
    • Effects of intensive blood pressure reduction on myocardial infarction and stroke in diabetes: a meta-analysis in 73 913 patients
    • Reboldi G, Gentile G, Angeli F, et al. Effects of intensive blood pressure reduction on myocardial infarction and stroke in diabetes: a meta-analysis in 73 913 patients. J Hypertens 2011; 29: 1253-1269.
    • (2011) J Hypertens , vol.29 , pp. 1253-1269
    • Reboldi, G.1    Gentile, G.2    Angeli, F.3
  • 204
    • 77951735232 scopus 로고    scopus 로고
    • Effects of intensive blood-pressure control in type 2 diabetes mellitus
    • ACCORD Study Group
    • ACCORD Study Group, Cushman WC, Evans GW, Byington RP, et al. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med 2010; 362: 1575-1585.
    • (2010) N Engl J Med , vol.362 , pp. 1575-1585
    • Cushman, W.C.1    Evans, G.W.2    Byington, R.P.3
  • 205
    • 34548420712 scopus 로고    scopus 로고
    • Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial
    • ADVANCE Collaborative Group.
    • ADVANCE Collaborative Group, Patel A, Chalmers J, Neal B, et al. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet 2007; 370: 829-840.
    • (2007) Lancet , vol.370 , pp. 829-840
    • Patel, A.1    Chalmers, J.2    Neal, B.3
  • 206
    • 18244368464 scopus 로고    scopus 로고
    • Systolic and diastolic blood pressure lowering as determinants of cardiovascular outcome
    • Wang JG, Staessen JA, Franklin SS, et al. Systolic and diastolic blood pressure lowering as determinants of cardiovascular outcome. Hypertension 2005; 45: 907-913.
    • (2005) Hypertension , vol.45 , pp. 907-913
    • Wang, J.G.1    Staessen, J.A.2    Franklin, S.S.3
  • 207
    • 77953468570 scopus 로고    scopus 로고
    • Blood pressure lowering treatment for preventing stroke recurrence: a systematic review and metaanalysis
    • Lakhan SE, Sapko MT. Blood pressure lowering treatment for preventing stroke recurrence: a systematic review and metaanalysis. Int Arch Med 2009; 2: 30.
    • (2009) Int Arch Med , vol.2 , pp. 30
    • Lakhan, S.E.1    Sapko, M.T.2
  • 208
    • 77950163226 scopus 로고    scopus 로고
    • Effect of early treatment with antihypertensive drugs on short and long-term mortality in patients with an acute cardiovascular event
    • Perez MI, Musini VM, Wright JM. Effect of early treatment with antihypertensive drugs on short and long-term mortality in patients with an acute cardiovascular event. Cochrane DB Syst Rev 2009; 4: CD006743.
    • (2009) Cochrane DB Syst Rev , vol.4
    • Perez, M.I.1    Musini, V.M.2    Wright, J.M.3
  • 209
    • 42049107348 scopus 로고    scopus 로고
    • Telmisartan, ramipril, or both in patients at high risk for vascular events
    • the ONTARGET investigators.
    • Yusuf S, Teo KK, Pogue J, et al, the ONTARGET investigators. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Eng J Med 2008; 358: 1547-1559.
    • (2008) N Eng J Med , vol.358 , pp. 1547-1559
    • Yusuf, S.1    Teo, K.K.2    Pogue, J.3
  • 210
    • 0034685403 scopus 로고    scopus 로고
    • Major cardiovascular events in hypertensive patients randomized to doxazosin versus chlorthalidone. The antihypertensive and lipidlowering treatment to prevent heart attack trial (ALLHAT).
    • ALLHAT Collaborative Research Group.
    • ALLHAT Collaborative Research Group. Major cardiovascular events in hypertensive patients randomized to doxazosin versus chlorthalidone. The antihypertensive and lipidlowering treatment to prevent heart attack trial (ALLHAT). JAMA 2000; 283: 1967-1975.
    • (2000) JAMA , vol.283 , pp. 1967-1975
  • 211
    • 77950187294 scopus 로고    scopus 로고
    • Renal outcomes with different fixed dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial
    • Bakris GL, Sarafidis PA, Weir MR, et al. Renal outcomes with different fixed dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial. Lancet 2010; 375: 1173-1181.
    • (2010) Lancet , vol.375 , pp. 1173-1181
    • Bakris, G.L.1    Sarafidis, P.A.2    Weir, M.R.3
  • 212
    • 24644443331 scopus 로고    scopus 로고
    • Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo- Scandinavian Cardiac Outcomes Trial Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial
    • Dahlöf B, Sever PS, Poulter NR, et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo- Scandinavian Cardiac Outcomes Trial Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet 2005; 366: 895-906.
    • (2005) Lancet , vol.366 , pp. 895-906
    • Dahlöf, B.1    Sever, P.S.2    Poulter, N.R.3
  • 213
    • 79955522788 scopus 로고    scopus 로고
    • Meta-analysis: impact of drug class on adherence to antihypertensives
    • Kronish IM, Woodward M, Sergie Z, et al. Meta-analysis: impact of drug class on adherence to antihypertensives. Circulation 2011; 123: 1611-1621.
    • (2011) Circulation , vol.123 , pp. 1611-1621
    • Kronish, I.M.1    Woodward, M.2    Sergie, Z.3
  • 214
    • 0032560807 scopus 로고    scopus 로고
    • Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction
    • Haffner SM, Lehto S, Rönnemaa T, et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998; 339: 229-234.
    • (1998) N Engl J Med , vol.339 , pp. 229-234
    • Haffner, S.M.1    Lehto, S.2    Rönnemaa, T.3
  • 215
    • 0037140211 scopus 로고    scopus 로고
    • Comparison of cardiovascular risk between patients with type 2 diabetes and those who had had a myocardial infarction: cross sectional and cohort studies
    • Evans JMM, Wang J, Morris AD. Comparison of cardiovascular risk between patients with type 2 diabetes and those who had had a myocardial infarction: cross sectional and cohort studies. BMJ 2002; 324: 939-942.
    • (2002) BMJ , vol.324 , pp. 939-942
    • Evans, J.M.M.1    Wang, J.2    Morris, A.D.3
  • 216
    • 0035212615 scopus 로고    scopus 로고
    • UKPDS 56: the UKPDS risk engine: a model for the risk of coronary heart disease in type 2 diabetes
    • Stevens R, Kothari V, Adler AI, et al. UKPDS 56: the UKPDS risk engine: a model for the risk of coronary heart disease in type 2 diabetes. Clin Sci 2001; 101: 671-679. www.dtu.ox.ac.uk/ index.php?maindoc=/riskengine.
    • (2001) Clin Sci , vol.101 , pp. 671-679
    • Stevens, R.1    Kothari, V.2    Adler, A.I.3
  • 217
    • 84898540498 scopus 로고    scopus 로고
    • The National Collaborating Centre for Chronic Conditions. Type 2 diabetes: the management of type 2 diabetes. NICE clinical guideline 87. London: Royal College of Physicians
    • The National Collaborating Centre for Chronic Conditions. Type 2 diabetes: the management of type 2 diabetes. NICE clinical guideline 87. London: Royal College of Physicians; 2009. http://www.nice.org.uk/nicemedia/pdf/ CG87NICEGuideline.pdf.
    • (2009)
  • 218
    • 80555128215 scopus 로고    scopus 로고
    • European guidelines on cardiovascular disease prevention in clinical practice
    • Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice.
    • Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. European guidelines on cardiovascular disease prevention in clinical practice. Eur J Cardiov Prev R 2007; 14: Suppl 2.
    • (2007) Eur J Cardiov Prev R , vol.14 , Issue.SUPPL. 2
  • 219
    • 84898544652 scopus 로고    scopus 로고
    • National Vascular Disease Prevention Alliance. Evidencebased practice guidelines for the assessment of absolute cardiovascular disease risk. Canberra: NHMRC
    • National Vascular Disease Prevention Alliance. Evidencebased practice guidelines for the assessment of absolute cardiovascular disease risk. Canberra: NHMRC; 2009.
    • (2009)
  • 220
    • 84898542679 scopus 로고    scopus 로고
    • New Zealand Guidelines Group. New Zealand cardiovascular guidelines handbook: a summary resource for primary care practitioners. 2nd ed. Wellington: New Zealand Guidelines Group
    • New Zealand Guidelines Group. New Zealand cardiovascular guidelines handbook: a summary resource for primary care practitioners. 2nd ed. Wellington: New Zealand Guidelines Group; 2009. http://www.moh.govt.nz and www. nzgg.org.nz.
    • (2009)
  • 221
    • 65749098338 scopus 로고    scopus 로고
    • Canadian Diabetes Association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada
    • Canadian Diabetes Association Clinical Practice Guidelines Expert Committee.
    • Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes 2008; 32: S95-S98. http:// www.diabetes.ca.
    • (2008) Can J Diabetes , vol.32
  • 222
    • 84898540101 scopus 로고    scopus 로고
    • Scottish Intercollegiate Guidelines Network. Risk estimation and the prevention of cardiovascular disease. Edinburgh: Scottish Intercollegiate Guidelines Network. (SIGN publication no. 97).
    • Scottish Intercollegiate Guidelines Network. Risk estimation and the prevention of cardiovascular disease. Edinburgh: Scottish Intercollegiate Guidelines Network; 2007. (SIGN publication no. 97). http://www.sign.ac.uk/guidelines/fulltext/97/ index.html.
    • (2007)
  • 223
    • 84898540103 scopus 로고    scopus 로고
    • World Health Organization. Prevention of cardiovascular disease: guidelines for assessment and management of cardiovascular risk. Geneva: World Health Organization
    • World Health Organization. Prevention of cardiovascular disease: guidelines for assessment and management of cardiovascular risk. Geneva: World Health Organization; 2007. http://whqlibdoc.who.int/publications/2007/9789241547178_ eng.pdf.
    • (2007)
  • 224
    • 0037472879 scopus 로고    scopus 로고
    • Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes
    • Gaede P, Vedel P, Larsen N, et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003; 348: 383-393.
    • (2003) N Engl J Med , vol.348 , pp. 383-393
    • Gaede, P.1    Vedel, P.2    Larsen, N.3
  • 225
    • 38949210220 scopus 로고    scopus 로고
    • Effect of a multifactorial intervention on mortality in type 2 diabetes
    • Gæde P, Lund-Andersen H, Parving H-H, et al. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 2008; 358: 580-591.
    • (2008) N Engl J Med , vol.358 , pp. 580-591
    • Gæde, P.1    Lund-Andersen, H.2    Parving, H-H.3
  • 226
    • 67650094615 scopus 로고    scopus 로고
    • The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials
    • Brugts JJ, Yetgin T, Hoeks SE, et al. The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials. BMJ 2009; 338: b2376.
    • (2009) BMJ , vol.338
    • Brugts, J.J.1    Yetgin, T.2    Hoeks, S.E.3
  • 227
    • 77954179995 scopus 로고    scopus 로고
    • Statins and all-cause mortality in high-risk primary prevention: a meta-analysis of 11 randomized controlled trials involving 65,229 participants
    • Ray KK, Seshasai SR, Erqou S, et al. Statins and all-cause mortality in high-risk primary prevention: a meta-analysis of 11 randomized controlled trials involving 65,229 participants. Arch Intern Med 2010; 170: 1024-1031.
    • (2010) Arch Intern Med , vol.170 , pp. 1024-1031
    • Ray, K.K.1    Seshasai, S.R.2    Erqou, S.3
  • 228
    • 4344683381 scopus 로고    scopus 로고
    • Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial
    • the CARDS investigators.
    • Colhoun HM, Betteridge DJ, Durrington PN, et al, the CARDS investigators. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet 2004; 364: 685-696.
    • (2004) Lancet , vol.364 , pp. 685-696
    • Colhoun, H.M.1    Betteridge, D.J.2    Durrington, P.N.3
  • 229
    • 79952052016 scopus 로고    scopus 로고
    • Statins for the primary prevention of cardiovascular disease
    • Taylor F, Ward K, Moore TH, et al. Statins for the primary prevention of cardiovascular disease. Cochrane DB Syst Rev 2011; 1: CD004816.
    • (2011) Cochrane DB Syst Rev , vol.1
    • Taylor, F.1    Ward, K.2    Moore, T.H.3
  • 230
    • 70449517205 scopus 로고    scopus 로고
    • A systematic review and economic evaluation of statins for the prevention of coronary events
    • iii-iv
    • Ward S, Lloyd Jones M, Pandor A, et al. A systematic review and economic evaluation of statins for the prevention of coronary events. Health Technol Assess 2007; 14: 1-160, iii-iv.
    • (2007) Health Technol Assess , vol.14 , pp. 1-160
    • Ward, S.1    Lloyd Jones, M.2    Pandor, A.3
  • 231
    • 64349105221 scopus 로고    scopus 로고
    • Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention
    • Amarenco P, Labreuche J. Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention. Lancet Neurol 2009; 8: 453-463.
    • (2009) Lancet Neurol , vol.8 , pp. 453-463
    • Amarenco, P.1    Labreuche, J.2
  • 232
    • 77952708442 scopus 로고    scopus 로고
    • Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis
    • Jun M, Foote C, Lv J, et al. Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis. Lancet 2010; 375: 1875-1884.
    • (2010) Lancet , vol.375 , pp. 1875-1884
    • Jun, M.1    Foote, C.2    Lv, J.3
  • 233
    • 33645216485 scopus 로고    scopus 로고
    • Fibrates in the prevention of cardiovascular disease in patients with type 2 diabetes mellitus: meta-analysis of randomised controlled trials
    • Allemann S, Diem P, Egger M, et al. Fibrates in the prevention of cardiovascular disease in patients with type 2 diabetes mellitus: meta-analysis of randomised controlled trials. Curr Med Res Opin 2006; 3: 617-623.
    • (2006) Curr Med Res Opin , vol.3 , pp. 617-623
    • Allemann, S.1    Diem, P.2    Egger, M.3
  • 234
    • 36049001784 scopus 로고    scopus 로고
    • Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial
    • The FIELD study Investigators.
    • Keech A, Mitchell P, Summanen P, et al, the FIELD study Investigators. Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial. Lancet 2007; 370: 1687-1697.
    • (2007) Lancet , vol.370 , pp. 1687-1697
    • Keech, A.1    Mitchell, P.2    Summanen, P.3
  • 235
    • 65649142619 scopus 로고    scopus 로고
    • Effect of fenofibrate on amputation events in people with type 2 diabetes mellitus (FIELD study): a prespecified analysis of a randomised controlled trial
    • The FIELD study investigators.
    • Rajamania P, Colman P, Lia L, et al, the FIELD study investigators. Effect of fenofibrate on amputation events in people with type 2 diabetes mellitus (FIELD study): a prespecified analysis of a randomised controlled trial. Lancet 2009; 373: 1780-1788.
    • (2009) Lancet , vol.373 , pp. 1780-1788
    • Rajamania, P.1    Colman, P.2    Lia, L.3
  • 236
    • 28044452217 scopus 로고    scopus 로고
    • Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial
    • Keech A, Simes RJ, Barter P, et al. Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet 2005; 366: 1849-1861.
    • (2005) Lancet , vol.366 , pp. 1849-1861
    • Keech, A.1    Simes, R.J.2    Barter, P.3
  • 237
    • 77951704587 scopus 로고    scopus 로고
    • Effects of combination lipid therapy in type 2 diabetes mellitus
    • The ACCORD Study Group.
    • The ACCORD Study Group. Effects of combination lipid therapy in type 2 diabetes mellitus. N Engl J Med 2010; 362: 1563-1574.
    • (2010) N Engl J Med , vol.362 , pp. 1563-1574
  • 238
    • 0037065502 scopus 로고    scopus 로고
    • Collaborative metaanalysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients
    • Antiplatelet Trialists' Collaboration.
    • Antiplatelet Trialists' Collaboration. Collaborative metaanalysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002; 324: 71-86.
    • (2002) BMJ , vol.324 , pp. 71-86
  • 239
    • 65849268320 scopus 로고    scopus 로고
    • Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials
    • Baigent C, Blackwell L, Collins R, et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet 2009; 373: 1849-1860.
    • (2009) Lancet , vol.373 , pp. 1849-1860
    • Baigent, C.1    Blackwell, L.2    Collins, R.3
  • 240
    • 30944467297 scopus 로고    scopus 로고
    • Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials
    • Berger JS, Roncaglioni MC, Avanzini F, et al. Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials. JAMA 2006; 295: 306-313.
    • (2006) JAMA , vol.295 , pp. 306-313
    • Berger, J.S.1    Roncaglioni, M.C.2    Avanzini, F.3
  • 241
    • 72249095825 scopus 로고    scopus 로고
    • Aspirin for the primary prevention of cardiovascular events: a systematic review and meta-analysis comparing patients with and without diabetes
    • Calvin AD, Aggarwal NR, Murad MH, et al. Aspirin for the primary prevention of cardiovascular events: a systematic review and meta-analysis comparing patients with and without diabetes. Diabetes Care 2009; 32: 2300-2306.
    • (2009) Diabetes Care , vol.32 , pp. 2300-2306
    • Calvin, A.D.1    Aggarwal, N.R.2    Murad, M.H.3
  • 242
    • 71749105108 scopus 로고    scopus 로고
    • Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials
    • De Berardis G, Sacco M, Strippoli GF, et al. Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials. BMJ 2009; 339: b4531.
    • (2009) BMJ , vol.339
    • De Berardis, G.1    Sacco, M.2    Strippoli, G.F.3
  • 243
    • 74449086639 scopus 로고    scopus 로고
    • Aspirin for primary prevention of cardiovascular events in patients with diabetes: a metaanalysis
    • Zhang C, Sun A, Zhang P, et al. Aspirin for primary prevention of cardiovascular events in patients with diabetes: a metaanalysis. Diabetes Res Clin Pract 2010; 87: 211-218.
    • (2010) Diabetes Res Clin Pract , vol.87 , pp. 211-218
    • Zhang, C.1    Sun, A.2    Zhang, P.3
  • 244
    • 65649145705 scopus 로고    scopus 로고
    • Effect of clopidogrel added to aspirin in patients with atrial fibrillation
    • Connolly SJ, Pogue J, Hart RG, et al. Effect of clopidogrel added to aspirin in patients with atrial fibrillation. N Engl J Med 2009; 360: 2066-2078.
    • (2009) N Engl J Med , vol.360 , pp. 2066-2078
    • Connolly, S.J.1    Pogue, J.2    Hart, R.G.3
  • 245
    • 84898547586 scopus 로고    scopus 로고
    • British Heart Foundation. ASCEND: A Study of Cardiovascular Events iN Diabetes
    • British Heart Foundation. ASCEND: A Study of Cardiovascular Events iN Diabetes. http://www.ctsu.ox.ac.uk/ascend.
  • 247
    • 0021191759 scopus 로고
    • The Wisconsin epidemiologic study of diabetic retinopathy III, Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years.
    • Klein R, Klein BEK, Moss SE, et al. The Wisconsin epidemiologic study of diabetic retinopathy III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 1984; 182: 527-532.
    • (1984) Arch Ophthalmol , vol.182 , pp. 527-532
    • Klein, R.1    Klein, B.E.K.2    Moss, S.E.3
  • 248
    • 0003569311 scopus 로고
    • Photocoagulation treatment of proliferative diabetic retinopath. Clinical application of DRS findings. DRS Report No. 8.
    • Diabetic Retinopathy Study Research Group.
    • Diabetic Retinopathy Study Research Group. Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of DRS findings. DRS Report No. 8. Ophthalmology 1981; 88: 583-600.
    • (1981) Ophthalmology , vol.88 , pp. 583-600
  • 249
    • 0003680199 scopus 로고
    • Early photocoagulation for diabetic retinopath. ETDRS Report No. 9.
    • Early Treatment Diabetic Retinopathy Study Research Group.
    • Early Treatment Diabetic Retinopathy Study Research Group. Early photocoagulation for diabetic retinopathy. ETDRS Report No. 9. Ophthalmology 1991; 98: 741-756.
    • (1991) Ophthalmology , vol.98 , pp. 741-756
  • 250
    • 0042932653 scopus 로고    scopus 로고
    • The Global Diabetic Retinopathy Project Group., Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales
    • Wilkinson CP, Ferris FL 3rd, Klein RE, et al, the Global Diabetic Retinopathy Project Group. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 2003; 110: 1677-1682.
    • (2003) Ophthalmology , vol.110 , pp. 1677-1682
    • Wilkinson, C.P.1    Ferris III, F.L.2    Klein, R.E.3
  • 251
    • 33645320857 scopus 로고    scopus 로고
    • Accuracy and reliability of teleophthalmology for diagnosing diabetic retinopathy and macular edema: a review of the literature
    • Whited JD. Accuracy and reliability of teleophthalmology for diagnosing diabetic retinopathy and macular edema: a review of the literature. Diabetes Technol Ther 2006; 8: 102-122.
    • (2006) Diabetes Technol Ther , vol.8 , pp. 102-122
    • Whited, J.D.1
  • 252
    • 0031916725 scopus 로고    scopus 로고
    • United Kingdom Prospective Diabetes Study 30: diabetic retinopathy at diagnosis of non-insulin-dependent diabetes mellitus and associated risk factors
    • Kohner EM, Aldington SJ, Stratton IM, et al. United Kingdom Prospective Diabetes Study 30: diabetic retinopathy at diagnosis of non-insulin-dependent diabetes mellitus and associated risk factors. Arch Ophthalmol 1998; 116: 297-303.
    • (1998) Arch Ophthalmol , vol.116 , pp. 297-303
    • Kohner, E.M.1    Aldington, S.J.2    Stratton, I.M.3
  • 253
    • 0021748399 scopus 로고
    • The Wisconsin epidemiologic study of diabetic retinopathy IV. Diabetic macular edema.
    • Klein R, Klein BEK, Moss SE, et al. The Wisconsin epidemiologic study of diabetic retinopathy IV. Diabetic macular edema. Ophthalmology 1984; 91: 1464-1474.
    • (1984) Ophthalmology , vol.91 , pp. 1464-1474
    • Klein, R.1    Klein, B.E.K.2    Moss, S.E.3
  • 254
    • 0037452226 scopus 로고    scopus 로고
    • Incidence of sight threatening retinopathy in patients with type 2 diabetes in the Liverpool Diabetic Eye Study: a cohort study
    • Younis N, Broadbent DM, Vora JP, et al. Incidence of sight threatening retinopathy in patients with type 2 diabetes in the Liverpool Diabetic Eye Study: a cohort study. Lancet 2003; 361: 195-200.
    • (2003) Lancet , vol.361 , pp. 195-200
    • Younis, N.1    Broadbent, D.M.2    Vora, J.P.3
  • 255
    • 84898541302 scopus 로고    scopus 로고
    • The National Collaborating Centre for Chronic Conditions. Type 2 diabetes: the management of type 2 diabetes. NICE clinical guideline 87. London: Royal College of Physicians
    • The National Collaborating Centre for Chronic Conditions. Type 2 diabetes: the management of type 2 diabetes. NICE clinical guideline 87. London: Royal College of Physicians; 2009. http:// www.nice.org.uk/nicemedia/pdf/CG87NICEGuideline.pdf.
    • (2009)
  • 256
    • 84875617224 scopus 로고    scopus 로고
    • Clinical practice recommendations 2012
    • American Diabetes Association.
    • American Diabetes Association. Clinical practice recommendations 2012. Diabetes Care 2012; 35: Suppl 1.
    • (2012) Diabetes Care , vol.35 , Issue.SUPPL. 1
  • 257
    • 65749098338 scopus 로고    scopus 로고
    • Canadian Diabetes Association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada
    • Canadian Diabetes Association Clinical Practice Guidelines Expert Committee.
    • Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes 2008; 32: S95-S98. http://www.diabetes.ca.
    • (2008) Can J Diabetes , vol.32
  • 258
    • 84898548516 scopus 로고    scopus 로고
    • Australian Diabetes Society for the Department of Health and Ageing. Guidelines for the management of diabetic retinopathy. Canberra: National Health and Medical Research Council
    • Australian Diabetes Society for the Department of Health and Ageing. Guidelines for the management of diabetic retinopathy. Canberra: National Health and Medical Research Council; 2008. www.nhmrc.gov.au/publications.
    • (2008)
  • 259
    • 84898544104 scopus 로고    scopus 로고
    • Scottish Intercollegiate Guidelines Network. SIGN 116. Management of diabetes: a national clinical guideline
    • Scottish Intercollegiate Guidelines Network. SIGN 116. Management of diabetes: a national clinical guideline, 2010. http://www.sign.ac.uk/pdf/sign116.pdf.
    • (2010)
  • 260
    • 0032511583 scopus 로고    scopus 로고
    • Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
    • UK Prospective Diabetes Study Group.
    • UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-853.
    • (1998) Lancet , vol.352 , pp. 837-853
  • 261
    • 0032511580 scopus 로고    scopus 로고
    • Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 38)
    • UK Prospective Diabetes Study Group.
    • UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 38). BMJ 1998; 317: 703-713.
    • (1998) BMJ , vol.317 , pp. 703-713
  • 262
    • 77954654472 scopus 로고    scopus 로고
    • Effects of medical therapies on retinopathy progression in type 2 diabetes
    • The ACCORD Study Group and ACCORD Eye Study Group.
    • The ACCORD Study Group and ACCORD Eye Study Group. Effects of medical therapies on retinopathy progression in type 2 diabetes. N Engl J Med 2010; 363: 233-244.
    • (2010) N Engl J Med , vol.363 , pp. 233-244
  • 263
    • 70449360911 scopus 로고    scopus 로고
    • Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes. New results from the ADVANCE trial.
    • The Advance Collaborative Group.
    • Zoungas S, de Galen B, Ninomiya T, et al, the Advance Collaborative Group. Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes. New results from the ADVANCE trial. Diabetes Care 2009; 32: 2068-2074.
    • (2009) Diabetes Care , vol.32 , pp. 2068-2074
    • Zoungas, S.1    de Galen, B.2    Ninomiya, T.3
  • 264
    • 0037472879 scopus 로고    scopus 로고
    • Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes
    • Gaede P, Vedel P, Larsen N, et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003; 348: 383-393.
    • (2003) N Engl J Med , vol.348 , pp. 383-393
    • Gaede, P.1    Vedel, P.2    Larsen, N.3
  • 265
    • 0036176161 scopus 로고    scopus 로고
    • K/ DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification
    • S1-S266, Kidney Foundation Disease Outcomes Quality Initiative.
    • Kidney Foundation Disease Outcomes Quality Initiative. K/ DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39: S1-S266.
    • (2002) Am J Kidney Dis , vol.39
  • 266
    • 84855185039 scopus 로고    scopus 로고
    • Standards of medical care in diabetes
    • American Diabetes Association.
    • American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 2012; 35: S11-S63.
    • (2012) Diabetes Care , vol.35
  • 267
    • 84898548093 scopus 로고    scopus 로고
    • Scottish Intercollegiate Guidelines Network. SIGN 116. Management of diabetes: a national clinical guideline
    • Scottish Intercollegiate Guidelines Network. SIGN 116. Management of diabetes: a national clinical guideline, 2010. http://www.sign.ac.uk/pdf/sign116.pdf.
    • (2010)
  • 268
    • 84898540052 scopus 로고    scopus 로고
    • National evidence based guideline for diagnosis, prevention and management of chronic kidney disease in type 2 diabetes. Canberra: Diabetes Australia and the NHMRC
    • Chadban S, Howell M, Twigg S, et al. National evidence based guideline for diagnosis, prevention and management of chronic kidney disease in type 2 diabetes. Canberra: Diabetes Australia and the NHMRC; 2009.
    • (2009)
    • Chadban, S.1    Howell, M.2    Twigg, S.3
  • 269
    • 84898548916 scopus 로고    scopus 로고
    • The National Collaborating Centre for Chronic Conditions. Type 2 diabetes: the management of type 2 diabetes. NICE clinical guideline 87. London: Royal College of Physicians
    • The National Collaborating Centre for Chronic Conditions. Type 2 diabetes: the management of type 2 diabetes. NICE clinical guideline 87. London: Royal College of Physicians; 2009. http:// www.nice.org.uk/nicemedia/pdf/CG87NICEGuideline.pdf.
    • (2009)
  • 270
    • 65749098338 scopus 로고    scopus 로고
    • Canadian Diabetes Association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada
    • Canadian Diabetes Association Clinical Practice Guidelines Expert Committee.
    • Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes 2008; 32: S95-S98. http:// www.diabetes.ca.
    • (2008) Can J Diabetes , vol.32
  • 271
    • 0032511583 scopus 로고    scopus 로고
    • Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
    • UK Prospective Diabetes Study Group.
    • UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-853.
    • (1998) Lancet , vol.352 , pp. 837-853
  • 272
    • 0032511580 scopus 로고    scopus 로고
    • Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 38)
    • UK Prospective Diabetes Study Group.
    • UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 38). BMJ 1998; 317: 703-713.
    • (1998) BMJ , vol.317 , pp. 703-713
  • 273
    • 45149131667 scopus 로고    scopus 로고
    • Effects of intensive glucose lowering in type 2 diabetes
    • The Action to Control Cardiovascular Risk in Diabetes Study Group.
    • The Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008; 358: 2545-2559.
    • (2008) N Engl J Med , vol.358 , pp. 2545-2559
  • 274
    • 45149133036 scopus 로고    scopus 로고
    • Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
    • The ADVANCE Collaborative Group.
    • The ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008; 358: 2560-2572.
    • (2008) N Engl J Med , vol.358 , pp. 2560-2572
  • 275
    • 84898542739 scopus 로고    scopus 로고
    • National evidence-based guideline on prevention, identification and management of foot complications in diabetes (part of the guidelines on management of type 2 diabetes). Melbourne: Diabetes Australia and the NHMRC
    • National evidence-based guideline on prevention, identification and management of foot complications in diabetes (part of the guidelines on management of type 2 diabetes). Melbourne: Diabetes Australia and the NHMRC; 2011. http:// www.diabetesaustralia.com.au.
    • (2011)
  • 276
    • 84898541262 scopus 로고    scopus 로고
    • Scottish Intercollegiate Guidelines Network. SIGN 116. Management of diabetes: a national clinical guideline
    • Scottish Intercollegiate Guidelines Network. SIGN 116. Management of diabetes: a national clinical guideline, 2010. http://www.sign.ac.uk/pdf/sign116.pdf.
    • (2010)
  • 277
    • 84856185057 scopus 로고    scopus 로고
    • Practical guidelines on the management and prevention of the diabetic foot 2011
    • The International Working Group on the Diabetic Foot Editorial Board.
    • Bakker K, Apelqvist J, Schaper NC, et al, the International Working Group on the Diabetic Foot Editorial Board. Practical guidelines on the management and prevention of the diabetic foot 2011. Diabetes Metab Res Rev 2012; 28: 225-231.
    • (2012) Diabetes Metab Res Rev , vol.28 , pp. 225-231
    • Bakker, K.1    Apelqvist, J.2    Schaper, N.C.3
  • 278
    • 84855185039 scopus 로고    scopus 로고
    • Standards of medical care in diabetes
    • American Diabetes Association.
    • American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 2012; 35: S11-S63.
    • (2012) Diabetes Care , vol.35
  • 279
    • 65749098338 scopus 로고    scopus 로고
    • Canadian Diabetes Association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada
    • Canadian Diabetes Association Clinical Practice Guidelines Expert Committee.
    • Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes 2008; 32: S95-S98. http:// www.diabetes.ca.
    • (2008) Can J Diabetes , vol.32
  • 280
    • 84898546122 scopus 로고    scopus 로고
    • National Institute for Clinical Excellence. Type 2 diabetes - footcare. London: National Institute for Clinical Excellence
    • National Institute for Clinical Excellence. Type 2 diabetes - footcare. London: National Institute for Clinical Excellence; 2004. http://www.nice.org.uk/page.aspx?o=101518.
    • (2004)
  • 282
    • 84856142553 scopus 로고    scopus 로고
    • Diagnosis and treatment of peripheral arterial disease in diabetic patients with a foot ulcer. A progress report of the International Working Group on the Diabetic Foot.
    • Schaper NC, Andros G, Apelqvist J, et al. Diagnosis and treatment of peripheral arterial disease in diabetic patients with a foot ulcer. A progress report of the International Working Group on the Diabetic Foot. Diabetes Metab Res Rev 2012; 28: 218-224.
    • (2012) Diabetes Metab Res Rev , vol.28 , pp. 218-224
    • Schaper, N.C.1    Andros, G.2    Apelqvist, J.3
  • 283
    • 84898545113 scopus 로고    scopus 로고
    • Scottish Intercollegiate Guidelines Network. SIGN 116. Management of diabetes: a national clinical guideline
    • Scottish Intercollegiate Guidelines Network. SIGN 116. Management of diabetes: a national clinical guideline, 2010. http://www.sign.ac.uk/pdf/sign116.pdf.
    • (2010)
  • 284
    • 65749098338 scopus 로고    scopus 로고
    • Canadian Diabetes Association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada
    • Canadian Diabetes Association Clinical Practice Guidelines Expert Committee.
    • Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes 2008; 32: S95-S98. http:// www.diabetes.ca.
    • (2008) Can J Diabetes , vol.32
  • 285
    • 84898539125 scopus 로고    scopus 로고
    • The National Collaborating Centre for Chronic Conditions. Type 2 diabetes: the management of type 2 diabetes. NICE clinical guideline 87. London: Royal College of Physicians
    • The National Collaborating Centre for Chronic Conditions. Type 2 diabetes: the management of type 2 diabetes. NICE clinical guideline 87. London: Royal College of Physicians; 2009. http://www.nice.org.uk/nicemedia/pdf/ CG87NICEGuideline.pdf.
    • (2009)
  • 286
    • 84855185039 scopus 로고    scopus 로고
    • Standards of medical care in diabetes
    • American Diabetes Association.
    • American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 2012; 35: S11-S63.
    • (2012) Diabetes Care , vol.35
  • 287
    • 20144389536 scopus 로고    scopus 로고
    • Diabetic neuropathies: a statement by the American Diabetes Association
    • The American Diabetes Association.
    • Boulton AJ, Vinik AI, Arezzo JC, et al, the American Diabetes Association. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care 2005; 28: 956-962.
    • (2005) Diabetes Care , vol.28 , pp. 956-962
    • Boulton, A.J.1    Vinik, A.I.2    Arezzo, J.C.3
  • 288
    • 45849095237 scopus 로고    scopus 로고
    • Efficacy safety, and tolerability of pregabalin treatment for painful diabetic peripheral neuropathy: findings from seven randomized, controlled trials across a range of doses
    • Freeman R, Durso-Decruz E, Emir B. Efficacy safety, and tolerability of pregabalin treatment for painful diabetic peripheral neuropathy: findings from seven randomized, controlled trials across a range of doses. Diabetes Care 2008; 31: 1448-1454.
    • (2008) Diabetes Care , vol.31 , pp. 1448-1454
    • Freeman, R.1    Durso-Decruz, E.2    Emir, B.3
  • 289
    • 37349086775 scopus 로고    scopus 로고
    • Duloxetine for the management of diabetic peripheral neuropathic pain: evidence- based findings from post hoc analysis of three multicenter, randomized, double-blind, placebo-controlled, parallel- group studies
    • Kajdasz DK, Iyengar S, Desaiah D, et al. Duloxetine for the management of diabetic peripheral neuropathic pain: evidence- based findings from post hoc analysis of three multicenter, randomized, double-blind, placebo-controlled, parallel- group studies. Clin Ther 2007; 29: S2536-S2546.
    • (2007) Clin Ther , vol.29
    • Kajdasz, D.K.1    Iyengar, S.2    Desaiah, D.3
  • 290
    • 0027466546 scopus 로고
    • The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study
    • Dyck PJ, Kratz KM, Karnes JL, et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology 1993; 43: 817-824.
    • (1993) Neurology , vol.43 , pp. 817-824
    • Dyck, P.J.1    Kratz, K.M.2    Karnes, J.L.3
  • 291
    • 2542429732 scopus 로고    scopus 로고
    • Diabetic somatic neuropathies (technical review)
    • Boulton AJM, Malik RA, Arezzo JC, et al. Diabetic somatic neuropathies (technical review). Diabetes Care 2004; 27: 1458-1486.
    • (2004) Diabetes Care , vol.27 , pp. 1458-1486
    • Boulton, A.J.M.1    Malik, R.A.2    Arezzo, J.C.3
  • 292
    • 0042405193 scopus 로고    scopus 로고
    • Diabetic autonomic neuropathy: a technical review
    • Vinik AI, Maser RE, Mitchell B, et al. Diabetic autonomic neuropathy: a technical review. Diabetes Care 2003; 26: 1553-1579.
    • (2003) Diabetes Care , vol.26 , pp. 1553-1579
    • Vinik, A.I.1    Maser, R.E.2    Mitchell, B.3
  • 293
    • 84898545880 scopus 로고    scopus 로고
    • Nutrition therapy for diabetic gastropathy
    • Franz MJ, Evert AB (eds). 2nd ed. Alexandria, VA: American Diabetes Association
    • Moore M. Nutrition therapy for diabetic gastropathy. In: Franz MJ, Evert AB (eds). American Diabetes Association guide to nutrition therapy for diabetes. 2nd ed. Alexandria, VA: American Diabetes Association; 2012: 355-369.
    • (2012) American Diabetes Association guide to nutrition therapy for diabetes , pp. 355-369
    • Moore, M.1
  • 294
    • 58149345150 scopus 로고    scopus 로고
    • Screening for malnutrition in the community: the MUST tool
    • Scott A. Screening for malnutrition in the community: the MUST tool. Br J Community Nurs 2008; 13: 410-412.
    • (2008) Br J Community Nurs , vol.13 , pp. 410-412
    • Scott, A.1
  • 295
    • 84898538769 scopus 로고    scopus 로고
    • Australian Diabetes Educators Association. Guidelines for the management and care of diabetes in the elderly. Weston, ACT: Australian Diabetes Educators Association
    • Australian Diabetes Educators Association. Guidelines for the management and care of diabetes in the elderly. Weston, ACT: Australian Diabetes Educators Association; 2003.
    • (2003)
  • 296
    • 0037968349 scopus 로고    scopus 로고
    • Guidelines for improving the care of the older person with diabetes mellitus, California Healthcare Foundation/American Geriatrics Society Panel on improving care for elders with diabetes.
    • Brown AF, Mangione CM, Saliba D, et al. Guidelines for improving the care of the older person with diabetes mellitus. California Healthcare Foundation/American Geriatrics Society Panel on improving care for elders with diabetes. J Am Geriatr Soc 2003; 51: S265-S280.
    • (2003) J Am Geriatr Soc , vol.51
    • Brown, A.F.1    Mangione, C.M.2    Saliba, D.3
  • 297
    • 84859404670 scopus 로고    scopus 로고
    • European Diabetes Working Party for Older People 2011 clinical guidelines for type 2 diabetes mellitus. Executive summary.
    • The European Diabetes Working Party for Older People.
    • Sinclair AJ, Paolisso G, Castro M, et al, the European Diabetes Working Party for Older People. European Diabetes Working Party for Older People 2011 clinical guidelines for type 2 diabetes mellitus. Executive summary. Diabetes Metab 2011; 37: S27-S38.
    • (2011) Diabetes Metab , vol.37
    • Sinclair, A.J.1    Paolisso, G.2    Castro, M.3
  • 298
    • 65749098338 scopus 로고    scopus 로고
    • Canadian Diabetes Association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada
    • Canadian Diabetes Association Clinical Practice Guidelines Expert Committee.
    • Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes 2008; 32: S95-S98. http:// www.diabetes.ca.
    • (2008) Can J Diabetes , vol.32
  • 299
    • 84898548750 scopus 로고    scopus 로고
    • Task and Finish Group of Diabetes UK. Good clinical practice guidelines for care home residents with diabetes. London: Diabetes UK
    • Task and Finish Group of Diabetes UK. Good clinical practice guidelines for care home residents with diabetes. London: Diabetes UK; 2011. http://www.diabetes.org.uk.
    • (2011)
  • 300
    • 0033964010 scopus 로고    scopus 로고
    • American Diabetes Association diabetes diagnostic criteria, advancing age, and cardiovascular disease risk profiles: results from the Third National Health and Nutrition Examination Survey
    • Resnick HE, Harris MI, Brock DB, et al. American Diabetes Association diabetes diagnostic criteria, advancing age, and cardiovascular disease risk profiles: results from the Third National Health and Nutrition Examination Survey. Diabetes Care 2000; 23: 176-180.
    • (2000) Diabetes Care , vol.23 , pp. 176-180
    • Resnick, H.E.1    Harris, M.I.2    Brock, D.B.3
  • 301
    • 0030272719 scopus 로고    scopus 로고
    • Diabetes education in the elderly: a 5 year follow-up of an interactive approach
    • Garcia R, Suarez R. Diabetes education in the elderly: a 5 year follow-up of an interactive approach. Patient Educ Couns 1997; 29: 87-97.
    • (1997) Patient Educ Couns , vol.29 , pp. 87-97
    • Garcia, R.1    Suarez, R.2
  • 302
    • 25644456143 scopus 로고    scopus 로고
    • Longitudinal predictors of reduced mobility and physical disability in patients with type 2 diabetes
    • Bruce DG, Davis WA, Davis TME. Longitudinal predictors of reduced mobility and physical disability in patients with type 2 diabetes. Diabetes Care 2005; 28: 2441-2447.
    • (2005) Diabetes Care , vol.28 , pp. 2441-2447
    • Bruce, D.G.1    Davis, W.A.2    Davis, T.M.E.3
  • 303
    • 33748740823 scopus 로고    scopus 로고
    • Risk of fracture in women with type 2 diabetes: the women's health initiative observational study
    • Bonds DE, Larson JC, Schwartz AV, et al. Risk of fracture in women with type 2 diabetes: the women's health initiative observational study. J Clin Endocrinol Metab 2006; 91: 3404-3410.
    • (2006) J Clin Endocrinol Metab , vol.91 , pp. 3404-3410
    • Bonds, D.E.1    Larson, J.C.2    Schwartz, A.V.3
  • 304
    • 34548209954 scopus 로고    scopus 로고
    • Physical activity and public health in older adults: recommendation from the American College of Sports Medicine and the American Heart Association
    • Nelson ME, Rejeski WJ, Blair SN, et al. Physical activity and public health in older adults: recommendation from the American College of Sports Medicine and the American Heart Association. Circulation 2007; 116: 1094-1105.
    • (2007) Circulation , vol.116 , pp. 1094-1105
    • Nelson, M.E.1    Rejeski, W.J.2    Blair, S.N.3
  • 305
    • 29044449855 scopus 로고    scopus 로고
    • Risk of dementia in diabetes-a systematic review
    • Biessels GJ, Staekenborg S, Brunner E, et al. Risk of dementia in diabetes-a systematic review. Lancet Neurol 2006; 5: 64-74.
    • (2006) Lancet Neurol , vol.5 , pp. 64-74
    • Biessels, G.J.1    Staekenborg, S.2    Brunner, E.3
  • 306
    • 33646383887 scopus 로고    scopus 로고
    • Improving metabolic control leads to better working memory in adults with type 2 diabetes
    • Ryan CM, Freed MI, Rood JA, et al. Improving metabolic control leads to better working memory in adults with type 2 diabetes. Diabetes Care 2006; 29: 345-351.
    • (2006) Diabetes Care , vol.29 , pp. 345-351
    • Ryan, C.M.1    Freed, M.I.2    Rood, J.A.3
  • 307
    • 34548428212 scopus 로고    scopus 로고
    • Depression, self-care, and medication adherence in type 2 diabetes: relationships across the full range of symptom severity
    • Gonzalez J, Safren S, Cagliero E, et al. Depression, self-care, and medication adherence in type 2 diabetes: relationships across the full range of symptom severity. Diabetes Care 2007; 30: 2222-2227.
    • (2007) Diabetes Care , vol.30 , pp. 2222-2227
    • Gonzalez, J.1    Safren, S.2    Cagliero, E.3
  • 308
    • 34250011130 scopus 로고    scopus 로고
    • Towards a minimum data set for intervention studies in type 2 diabetes in older people
    • Sinclair AJ. Towards a minimum data set for intervention studies in type 2 diabetes in older people. J Nutr Health Aging 2007; 11: 289-293.
    • (2007) J Nutr Health Aging , vol.11 , pp. 289-293
    • Sinclair, A.J.1
  • 309
    • 0035374464 scopus 로고    scopus 로고
    • Prevalence of diabetes in care home residents
    • Sinclair AJ, Gadsby R, Penfold S, et al. Prevalence of diabetes in care home residents. Diabetes Care 2001; 24: 1066-1068.
    • (2001) Diabetes Care , vol.24 , pp. 1066-1068
    • Sinclair, A.J.1    Gadsby, R.2    Penfold, S.3
  • 310
    • 46449117004 scopus 로고    scopus 로고
    • The effect of comorbid illness and functional status on the expected benefits of intensive glucose in older patients with type 2 diabetes: a decision analysis
    • Huang ES, Zhang Q, Gandra N, et al. The effect of comorbid illness and functional status on the expected benefits of intensive glucose in older patients with type 2 diabetes: a decision analysis. Ann Intern Med 2008: 149: 11-19.
    • (2008) Ann Intern Med , vol.149 , pp. 11-19
    • Huang, E.S.1    Zhang, Q.2    Gandra, N.3
  • 311
    • 37149006184 scopus 로고    scopus 로고
    • Management of type 2 diabetes in treatment-naive elderly patients: benefits and risks of vildagliptin monotherapy
    • Pratley RE, Rosenstock J, Pi-Sunyer FX, et al. Management of type 2 diabetes in treatment-naive elderly patients: benefits and risks of vildagliptin monotherapy. Diabetes Care 2007; 30: 3017-3022.
    • (2007) Diabetes Care , vol.30 , pp. 3017-3022
    • Pratley, R.E.1    Rosenstock, J.2    Pi-Sunyer, F.X.3
  • 312
    • 33846580098 scopus 로고    scopus 로고
    • Combination of oral antidiabetic agents with basal insulin versus premixed insulin alone in randomised elderly patients with type 2 diabetes mellitus
    • Janka HU, Plewe G, Busch K. Combination of oral antidiabetic agents with basal insulin versus premixed insulin alone in randomised elderly patients with type 2 diabetes mellitus. JAGS 2007; 55: 182-188.
    • (2007) JAGS , vol.55 , pp. 182-188
    • Janka, H.U.1    Plewe, G.2    Busch, K.3
  • 313
    • 42949112210 scopus 로고    scopus 로고
    • Treatment of hypertension in patients 80 years of age or older
    • The YVET Study Group.
    • Beckett NS, Peters R, Fletcher AE, et al, the YVET Study Group. Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008; 358: 1887-1898.
    • (2008) N Engl J Med , vol.358 , pp. 1887-1898
    • Beckett, N.S.1    Peters, R.2    Fletcher, A.E.3
  • 314
    • 26244432388 scopus 로고    scopus 로고
    • Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins
    • the Cholesterol Treatment Trialists' Collaborators.
    • Baigent C, Keech A, Kearney PM, et al, the Cholesterol Treatment Trialists' Collaborators. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 2005; 366: 1267-1278.
    • (2005) Lancet , vol.366 , pp. 1267-1278
    • Baigent, C.1    Keech, A.2    Kearney, P.M.3
  • 315
    • 4344683381 scopus 로고    scopus 로고
    • Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial
    • the CARDS investigators.
    • Colhoun HM, Betteridge DJ, Durrington PN, et al, the CARDS investigators. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet 2004; 364: 685-696.
    • (2004) Lancet , vol.364 , pp. 685-696
    • Colhoun, H.M.1    Betteridge, D.J.2    Durrington, P.N.3
  • 316
    • 28044452217 scopus 로고    scopus 로고
    • Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial
    • The FIELD study investigators.
    • Keech A, Simes RJ, Barter P, et al, the FIELD study investigators. Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet 2005; 366: 1849-1861.
    • (2005) Lancet , vol.366 , pp. 1849-1861
    • Keech, A.1    Simes, R.J.2    Barter, P.3
  • 317
    • 71549151349 scopus 로고    scopus 로고
    • Special considerations in the management and education of older persons with diabetes
    • American Association of Diabetes Educators.
    • American Association of Diabetes Educators. Special considerations in the management and education of older persons with diabetes. Diabetes Educ 2009; 35: S11-S63.
    • (2009) Diabetes Educ , vol.35
  • 318
    • 33845366289 scopus 로고    scopus 로고
    • Diabetes self-management education for older adults: general principles and practical application
    • Suhl E, Bunsignore P. Diabetes self-management education for older adults: general principles and practical application. Diabetes Spect 2006; 19: 234-250.
    • (2006) Diabetes Spect , vol.19 , pp. 234-250
    • Suhl, E.1    Bunsignore, P.2
  • 319
    • 84855185039 scopus 로고    scopus 로고
    • Standards of medical care in diabetes
    • American Diabetes Association.
    • American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 2012; 35: S11-S63.
    • (2012) Diabetes Care , vol.35
  • 320
    • 66549097705 scopus 로고    scopus 로고
    • American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control
    • Moghissi ES, Korytkowski MT, DiNardo M, et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care 2009; 32: 1119-1131.
    • (2009) Diabetes Care , vol.32 , pp. 1119-1131
    • Moghissi, E.S.1    Korytkowski, M.T.2    DiNardo, M.3
  • 321
    • 65749098338 scopus 로고    scopus 로고
    • Canadian Diabetes Association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada
    • Canadian Diabetes Association Clinical Practice Guidelines Expert Committee.
    • Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes 2008; 32: S95-S98. http:// www.diabetes.ca.
    • (2008) Can J Diabetes , vol.32
  • 322
    • 0842268332 scopus 로고    scopus 로고
    • Management of diabetes and hyperglycemia in hospitals
    • Clement S, Braithwaite SS, Magee MF, et al. Management of diabetes and hyperglycemia in hospitals. Diabetes Care 2004; 27: 553-597.
    • (2004) Diabetes Care , vol.27 , pp. 553-597
    • Clement, S.1    Braithwaite, S.S.2    Magee, M.F.3
  • 323
    • 63249128249 scopus 로고    scopus 로고
    • Intensive versus conventional glucose control in critically ill patients
    • The NICE-SUGAR Study investigators.
    • Finfer S, Chittock DR, Su SY, et al, the NICE-SUGAR Study investigators. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009; 360: 1283-1297.
    • (2009) N Engl J Med , vol.360 , pp. 1283-1297
    • Finfer, S.1    Chittock, D.R.2    Su, S.Y.3
  • 324
    • 65349096195 scopus 로고    scopus 로고
    • Intensive insulin therapy and mortality among critically ill patients: a metaanalysis including NICE-SUGAR study data
    • Griesdale DE, de Souza RJ, van Dam RM, et al. Intensive insulin therapy and mortality among critically ill patients: a metaanalysis including NICE-SUGAR study data. CMAJ 2009; 180: 821-827.
    • (2009) CMAJ , vol.180 , pp. 821-827
    • Griesdale, D.E.1    de Souza, R.J.2    van Dam, R.M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.